{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting git+git://github.com/titipata/pubmed_parser.git\n",
      "  Cloning git://github.com/titipata/pubmed_parser.git to c:\\users\\zubin roy\\appdata\\local\\temp\\pip-req-build-ktj9sdt5\n",
      "Requirement already satisfied: lxml in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (4.5.2)\n",
      "Requirement already satisfied: unidecode in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (1.2.0)\n",
      "Requirement already satisfied: requests in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (2.24.0)\n",
      "Requirement already satisfied: six in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (1.15.0)\n",
      "Requirement already satisfied: numpy in c:\\users\\zubin roy\\appdata\\roaming\\python\\python38\\site-packages (from pubmed-parser==0.2.2) (1.20.2)\n",
      "Requirement already satisfied: pytest in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (5.4.3)\n",
      "Requirement already satisfied: pytest-cov in c:\\programdata\\anaconda3\\lib\\site-packages (from pubmed-parser==0.2.2) (2.11.1)\n",
      "Requirement already satisfied: py>=1.5.0 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (1.9.0)Note: you may need to restart the kernel to use updated packages.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  Running command git clone -q git://github.com/titipata/pubmed_parser.git 'C:\\Users\\Zubin Roy\\AppData\\Local\\Temp\\pip-req-build-ktj9sdt5'\n",
      "WARNING: You are using pip version 21.0.1; however, version 21.1.1 is available.\n",
      "You should consider upgrading via the 'C:\\ProgramData\\Anaconda3\\python.exe -m pip install --upgrade pip' command.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Requirement already satisfied: packaging in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (20.4)\n",
      "Requirement already satisfied: attrs>=17.4.0 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (19.3.0)\n",
      "Requirement already satisfied: more-itertools>=4.0.0 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (8.4.0)\n",
      "Requirement already satisfied: pluggy<1.0,>=0.12 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (0.13.1)\n",
      "Requirement already satisfied: wcwidth in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (0.2.5)\n",
      "Requirement already satisfied: atomicwrites>=1.0 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (1.4.0)\n",
      "Requirement already satisfied: colorama in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest->pubmed-parser==0.2.2) (0.4.3)\n",
      "Requirement already satisfied: pyparsing>=2.0.2 in c:\\programdata\\anaconda3\\lib\\site-packages (from packaging->pytest->pubmed-parser==0.2.2) (2.4.7)\n",
      "Requirement already satisfied: coverage>=5.2.1 in c:\\programdata\\anaconda3\\lib\\site-packages (from pytest-cov->pubmed-parser==0.2.2) (5.5)\n",
      "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in c:\\programdata\\anaconda3\\lib\\site-packages (from requests->pubmed-parser==0.2.2) (1.25.9)\n",
      "Requirement already satisfied: chardet<4,>=3.0.2 in c:\\programdata\\anaconda3\\lib\\site-packages (from requests->pubmed-parser==0.2.2) (3.0.4)\n",
      "Requirement already satisfied: idna<3,>=2.5 in c:\\programdata\\anaconda3\\lib\\site-packages (from requests->pubmed-parser==0.2.2) (2.10)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\programdata\\anaconda3\\lib\\site-packages (from requests->pubmed-parser==0.2.2) (2020.6.20)\n"
     ]
    }
   ],
   "source": [
    "pip install git+git://github.com/titipata/pubmed_parser.git"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pubmed_parser as pp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1062\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "\n",
    "list = os.listdir(r\"E:\\UNO_Internship\\pubmed_Dr.Dario\\GZ_unzipped_file\") # dir is your directory path\n",
    "number_files = len(list)\n",
    "print (number_files)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['pubmed21n0001.xml.gz',\n",
       " 'pubmed21n0002.xml.gz',\n",
       " 'pubmed21n0003.xml.gz',\n",
       " 'pubmed21n0004.xml.gz',\n",
       " 'pubmed21n0005.xml.gz',\n",
       " 'pubmed21n0006.xml.gz',\n",
       " 'pubmed21n0007.xml.gz',\n",
       " 'pubmed21n0008.xml.gz',\n",
       " 'pubmed21n0009.xml.gz',\n",
       " 'pubmed21n0010.xml.gz',\n",
       " 'pubmed21n0011.xml.gz',\n",
       " 'pubmed21n0012.xml.gz',\n",
       " 'pubmed21n0013.xml.gz',\n",
       " 'pubmed21n0014.xml.gz',\n",
       " 'pubmed21n0015.xml.gz',\n",
       " 'pubmed21n0016.xml.gz',\n",
       " 'pubmed21n0017.xml.gz',\n",
       " 'pubmed21n0018.xml.gz',\n",
       " 'pubmed21n0019.xml.gz',\n",
       " 'pubmed21n0020.xml.gz',\n",
       " 'pubmed21n0021.xml.gz',\n",
       " 'pubmed21n0022.xml.gz',\n",
       " 'pubmed21n0023.xml.gz',\n",
       " 'pubmed21n0024.xml.gz',\n",
       " 'pubmed21n0025.xml.gz',\n",
       " 'pubmed21n0026.xml.gz',\n",
       " 'pubmed21n0027.xml.gz',\n",
       " 'pubmed21n0028.xml.gz',\n",
       " 'pubmed21n0029.xml.gz',\n",
       " 'pubmed21n0030.xml.gz',\n",
       " 'pubmed21n0031.xml.gz',\n",
       " 'pubmed21n0032.xml.gz',\n",
       " 'pubmed21n0033.xml.gz',\n",
       " 'pubmed21n0034.xml.gz',\n",
       " 'pubmed21n0035.xml.gz',\n",
       " 'pubmed21n0036.xml.gz',\n",
       " 'pubmed21n0037.xml.gz',\n",
       " 'pubmed21n0038.xml.gz',\n",
       " 'pubmed21n0039.xml.gz',\n",
       " 'pubmed21n0040.xml.gz',\n",
       " 'pubmed21n0041.xml.gz',\n",
       " 'pubmed21n0042.xml.gz',\n",
       " 'pubmed21n0043.xml.gz',\n",
       " 'pubmed21n0044.xml.gz',\n",
       " 'pubmed21n0045.xml.gz',\n",
       " 'pubmed21n0046.xml.gz',\n",
       " 'pubmed21n0047.xml.gz',\n",
       " 'pubmed21n0048.xml.gz',\n",
       " 'pubmed21n0049.xml.gz',\n",
       " 'pubmed21n0050.xml.gz',\n",
       " 'pubmed21n0051.xml.gz',\n",
       " 'pubmed21n0052.xml.gz',\n",
       " 'pubmed21n0053.xml.gz',\n",
       " 'pubmed21n0054.xml.gz',\n",
       " 'pubmed21n0055.xml.gz',\n",
       " 'pubmed21n0056.xml.gz',\n",
       " 'pubmed21n0057.xml.gz',\n",
       " 'pubmed21n0058.xml.gz',\n",
       " 'pubmed21n0059.xml.gz',\n",
       " 'pubmed21n0060.xml.gz',\n",
       " 'pubmed21n0061.xml.gz',\n",
       " 'pubmed21n0062.xml.gz',\n",
       " 'pubmed21n0063.xml.gz',\n",
       " 'pubmed21n0064.xml.gz',\n",
       " 'pubmed21n0065.xml.gz',\n",
       " 'pubmed21n0066.xml.gz',\n",
       " 'pubmed21n0067.xml.gz',\n",
       " 'pubmed21n0068.xml.gz',\n",
       " 'pubmed21n0069.xml.gz',\n",
       " 'pubmed21n0070.xml.gz',\n",
       " 'pubmed21n0071.xml.gz',\n",
       " 'pubmed21n0072.xml.gz',\n",
       " 'pubmed21n0073.xml.gz',\n",
       " 'pubmed21n0074.xml.gz',\n",
       " 'pubmed21n0075.xml.gz',\n",
       " 'pubmed21n0076.xml.gz',\n",
       " 'pubmed21n0077.xml.gz',\n",
       " 'pubmed21n0078.xml.gz',\n",
       " 'pubmed21n0079.xml.gz',\n",
       " 'pubmed21n0080.xml.gz',\n",
       " 'pubmed21n0081.xml.gz',\n",
       " 'pubmed21n0082.xml.gz',\n",
       " 'pubmed21n0083.xml.gz',\n",
       " 'pubmed21n0084.xml.gz',\n",
       " 'pubmed21n0085.xml.gz',\n",
       " 'pubmed21n0086.xml.gz',\n",
       " 'pubmed21n0087.xml.gz',\n",
       " 'pubmed21n0088.xml.gz',\n",
       " 'pubmed21n0089.xml.gz',\n",
       " 'pubmed21n0090.xml.gz',\n",
       " 'pubmed21n0091.xml.gz',\n",
       " 'pubmed21n0092.xml.gz',\n",
       " 'pubmed21n0093.xml.gz',\n",
       " 'pubmed21n0094.xml.gz',\n",
       " 'pubmed21n0095.xml.gz',\n",
       " 'pubmed21n0096.xml.gz',\n",
       " 'pubmed21n0097.xml.gz',\n",
       " 'pubmed21n0098.xml.gz',\n",
       " 'pubmed21n0099.xml.gz',\n",
       " 'pubmed21n0100.xml.gz',\n",
       " 'pubmed21n0101.xml.gz',\n",
       " 'pubmed21n0102.xml.gz',\n",
       " 'pubmed21n0103.xml.gz',\n",
       " 'pubmed21n0104.xml.gz',\n",
       " 'pubmed21n0105.xml.gz',\n",
       " 'pubmed21n0106.xml.gz',\n",
       " 'pubmed21n0107.xml.gz',\n",
       " 'pubmed21n0108.xml.gz',\n",
       " 'pubmed21n0109.xml.gz',\n",
       " 'pubmed21n0110.xml.gz',\n",
       " 'pubmed21n0111.xml.gz',\n",
       " 'pubmed21n0112.xml.gz',\n",
       " 'pubmed21n0113.xml.gz',\n",
       " 'pubmed21n0114.xml.gz',\n",
       " 'pubmed21n0115.xml.gz',\n",
       " 'pubmed21n0116.xml.gz',\n",
       " 'pubmed21n0117.xml.gz',\n",
       " 'pubmed21n0118.xml.gz',\n",
       " 'pubmed21n0119.xml.gz',\n",
       " 'pubmed21n0120.xml.gz',\n",
       " 'pubmed21n0121.xml.gz',\n",
       " 'pubmed21n0122.xml.gz',\n",
       " 'pubmed21n0123.xml.gz',\n",
       " 'pubmed21n0124.xml.gz',\n",
       " 'pubmed21n0125.xml.gz',\n",
       " 'pubmed21n0126.xml.gz',\n",
       " 'pubmed21n0127.xml.gz',\n",
       " 'pubmed21n0128.xml.gz',\n",
       " 'pubmed21n0129.xml.gz',\n",
       " 'pubmed21n0130.xml.gz',\n",
       " 'pubmed21n0131.xml.gz',\n",
       " 'pubmed21n0132.xml.gz',\n",
       " 'pubmed21n0133.xml.gz',\n",
       " 'pubmed21n0134.xml.gz',\n",
       " 'pubmed21n0135.xml.gz',\n",
       " 'pubmed21n0136.xml.gz',\n",
       " 'pubmed21n0137.xml.gz',\n",
       " 'pubmed21n0138.xml.gz',\n",
       " 'pubmed21n0139.xml.gz',\n",
       " 'pubmed21n0140.xml.gz',\n",
       " 'pubmed21n0141.xml.gz',\n",
       " 'pubmed21n0142.xml.gz',\n",
       " 'pubmed21n0143.xml.gz',\n",
       " 'pubmed21n0144.xml.gz',\n",
       " 'pubmed21n0145.xml.gz',\n",
       " 'pubmed21n0146.xml.gz',\n",
       " 'pubmed21n0147.xml.gz',\n",
       " 'pubmed21n0148.xml.gz',\n",
       " 'pubmed21n0149.xml.gz',\n",
       " 'pubmed21n0150.xml.gz',\n",
       " 'pubmed21n0151.xml.gz',\n",
       " 'pubmed21n0152.xml.gz',\n",
       " 'pubmed21n0153.xml.gz',\n",
       " 'pubmed21n0154.xml.gz',\n",
       " 'pubmed21n0155.xml.gz',\n",
       " 'pubmed21n0156.xml.gz',\n",
       " 'pubmed21n0157.xml.gz',\n",
       " 'pubmed21n0158.xml.gz',\n",
       " 'pubmed21n0159.xml.gz',\n",
       " 'pubmed21n0160.xml.gz',\n",
       " 'pubmed21n0161.xml.gz',\n",
       " 'pubmed21n0162.xml.gz',\n",
       " 'pubmed21n0163.xml.gz',\n",
       " 'pubmed21n0164.xml.gz',\n",
       " 'pubmed21n0165.xml.gz',\n",
       " 'pubmed21n0166.xml.gz',\n",
       " 'pubmed21n0167.xml.gz',\n",
       " 'pubmed21n0168.xml.gz',\n",
       " 'pubmed21n0169.xml.gz',\n",
       " 'pubmed21n0170.xml.gz',\n",
       " 'pubmed21n0171.xml.gz',\n",
       " 'pubmed21n0172.xml.gz',\n",
       " 'pubmed21n0173.xml.gz',\n",
       " 'pubmed21n0174.xml.gz',\n",
       " 'pubmed21n0175.xml.gz',\n",
       " 'pubmed21n0176.xml.gz',\n",
       " 'pubmed21n0177.xml.gz',\n",
       " 'pubmed21n0178.xml.gz',\n",
       " 'pubmed21n0179.xml.gz',\n",
       " 'pubmed21n0180.xml.gz',\n",
       " 'pubmed21n0181.xml.gz',\n",
       " 'pubmed21n0182.xml.gz',\n",
       " 'pubmed21n0183.xml.gz',\n",
       " 'pubmed21n0184.xml.gz',\n",
       " 'pubmed21n0185.xml.gz',\n",
       " 'pubmed21n0186.xml.gz',\n",
       " 'pubmed21n0187.xml.gz',\n",
       " 'pubmed21n0188.xml.gz',\n",
       " 'pubmed21n0189.xml.gz',\n",
       " 'pubmed21n0190.xml.gz',\n",
       " 'pubmed21n0191.xml.gz',\n",
       " 'pubmed21n0192.xml.gz',\n",
       " 'pubmed21n0193.xml.gz',\n",
       " 'pubmed21n0194.xml.gz',\n",
       " 'pubmed21n0195.xml.gz',\n",
       " 'pubmed21n0196.xml.gz',\n",
       " 'pubmed21n0197.xml.gz',\n",
       " 'pubmed21n0198.xml.gz',\n",
       " 'pubmed21n0199.xml.gz',\n",
       " 'pubmed21n0200.xml.gz',\n",
       " 'pubmed21n0201.xml.gz',\n",
       " 'pubmed21n0202.xml.gz',\n",
       " 'pubmed21n0203.xml.gz',\n",
       " 'pubmed21n0204.xml.gz',\n",
       " 'pubmed21n0205.xml.gz',\n",
       " 'pubmed21n0206.xml.gz',\n",
       " 'pubmed21n0207.xml.gz',\n",
       " 'pubmed21n0208.xml.gz',\n",
       " 'pubmed21n0209.xml.gz',\n",
       " 'pubmed21n0210.xml.gz',\n",
       " 'pubmed21n0211.xml.gz',\n",
       " 'pubmed21n0212.xml.gz',\n",
       " 'pubmed21n0213.xml.gz',\n",
       " 'pubmed21n0214.xml.gz',\n",
       " 'pubmed21n0215.xml.gz',\n",
       " 'pubmed21n0216.xml.gz',\n",
       " 'pubmed21n0217.xml.gz',\n",
       " 'pubmed21n0218.xml.gz',\n",
       " 'pubmed21n0219.xml.gz',\n",
       " 'pubmed21n0220.xml.gz',\n",
       " 'pubmed21n0221.xml.gz',\n",
       " 'pubmed21n0222.xml.gz',\n",
       " 'pubmed21n0223.xml.gz',\n",
       " 'pubmed21n0224.xml.gz',\n",
       " 'pubmed21n0225.xml.gz',\n",
       " 'pubmed21n0226.xml.gz',\n",
       " 'pubmed21n0227.xml.gz',\n",
       " 'pubmed21n0228.xml.gz',\n",
       " 'pubmed21n0229.xml.gz',\n",
       " 'pubmed21n0230.xml.gz',\n",
       " 'pubmed21n0231.xml.gz',\n",
       " 'pubmed21n0232.xml.gz',\n",
       " 'pubmed21n0233.xml.gz',\n",
       " 'pubmed21n0234.xml.gz',\n",
       " 'pubmed21n0235.xml.gz',\n",
       " 'pubmed21n0236.xml.gz',\n",
       " 'pubmed21n0237.xml.gz',\n",
       " 'pubmed21n0238.xml.gz',\n",
       " 'pubmed21n0239.xml.gz',\n",
       " 'pubmed21n0240.xml.gz',\n",
       " 'pubmed21n0241.xml.gz',\n",
       " 'pubmed21n0242.xml.gz',\n",
       " 'pubmed21n0243.xml.gz',\n",
       " 'pubmed21n0244.xml.gz',\n",
       " 'pubmed21n0245.xml.gz',\n",
       " 'pubmed21n0246.xml.gz',\n",
       " 'pubmed21n0247.xml.gz',\n",
       " 'pubmed21n0248.xml.gz',\n",
       " 'pubmed21n0249.xml.gz',\n",
       " 'pubmed21n0250.xml.gz',\n",
       " 'pubmed21n0251.xml.gz',\n",
       " 'pubmed21n0252.xml.gz',\n",
       " 'pubmed21n0253.xml.gz',\n",
       " 'pubmed21n0254.xml.gz',\n",
       " 'pubmed21n0255.xml.gz',\n",
       " 'pubmed21n0256.xml.gz',\n",
       " 'pubmed21n0257.xml.gz',\n",
       " 'pubmed21n0258.xml.gz',\n",
       " 'pubmed21n0259.xml.gz',\n",
       " 'pubmed21n0260.xml.gz',\n",
       " 'pubmed21n0261.xml.gz',\n",
       " 'pubmed21n0262.xml.gz',\n",
       " 'pubmed21n0263.xml.gz',\n",
       " 'pubmed21n0264.xml.gz',\n",
       " 'pubmed21n0265.xml.gz',\n",
       " 'pubmed21n0266.xml.gz',\n",
       " 'pubmed21n0267.xml.gz',\n",
       " 'pubmed21n0268.xml.gz',\n",
       " 'pubmed21n0269.xml.gz',\n",
       " 'pubmed21n0270.xml.gz',\n",
       " 'pubmed21n0271.xml.gz',\n",
       " 'pubmed21n0272.xml.gz',\n",
       " 'pubmed21n0273.xml.gz',\n",
       " 'pubmed21n0274.xml.gz',\n",
       " 'pubmed21n0275.xml.gz',\n",
       " 'pubmed21n0276.xml.gz',\n",
       " 'pubmed21n0277.xml.gz',\n",
       " 'pubmed21n0278.xml.gz',\n",
       " 'pubmed21n0279.xml.gz',\n",
       " 'pubmed21n0280.xml.gz',\n",
       " 'pubmed21n0281.xml.gz',\n",
       " 'pubmed21n0282.xml.gz',\n",
       " 'pubmed21n0283.xml.gz',\n",
       " 'pubmed21n0284.xml.gz',\n",
       " 'pubmed21n0285.xml.gz',\n",
       " 'pubmed21n0286.xml.gz',\n",
       " 'pubmed21n0287.xml.gz',\n",
       " 'pubmed21n0288.xml.gz',\n",
       " 'pubmed21n0289.xml.gz',\n",
       " 'pubmed21n0290.xml.gz',\n",
       " 'pubmed21n0291.xml.gz',\n",
       " 'pubmed21n0292.xml.gz',\n",
       " 'pubmed21n0293.xml.gz',\n",
       " 'pubmed21n0294.xml.gz',\n",
       " 'pubmed21n0295.xml.gz',\n",
       " 'pubmed21n0296.xml.gz',\n",
       " 'pubmed21n0297.xml.gz',\n",
       " 'pubmed21n0298.xml.gz',\n",
       " 'pubmed21n0299.xml.gz',\n",
       " 'pubmed21n0300.xml.gz',\n",
       " 'pubmed21n0301.xml.gz',\n",
       " 'pubmed21n0302.xml.gz',\n",
       " 'pubmed21n0303.xml.gz',\n",
       " 'pubmed21n0304.xml.gz',\n",
       " 'pubmed21n0305.xml.gz',\n",
       " 'pubmed21n0306.xml.gz',\n",
       " 'pubmed21n0307.xml.gz',\n",
       " 'pubmed21n0308.xml.gz',\n",
       " 'pubmed21n0309.xml.gz',\n",
       " 'pubmed21n0310.xml.gz',\n",
       " 'pubmed21n0311.xml.gz',\n",
       " 'pubmed21n0312.xml.gz',\n",
       " 'pubmed21n0313.xml.gz',\n",
       " 'pubmed21n0314.xml.gz',\n",
       " 'pubmed21n0315.xml.gz',\n",
       " 'pubmed21n0316.xml.gz',\n",
       " 'pubmed21n0317.xml.gz',\n",
       " 'pubmed21n0318.xml.gz',\n",
       " 'pubmed21n0319.xml.gz',\n",
       " 'pubmed21n0320.xml.gz',\n",
       " 'pubmed21n0321.xml.gz',\n",
       " 'pubmed21n0322.xml.gz',\n",
       " 'pubmed21n0323.xml.gz',\n",
       " 'pubmed21n0324.xml.gz',\n",
       " 'pubmed21n0325.xml.gz',\n",
       " 'pubmed21n0326.xml.gz',\n",
       " 'pubmed21n0327.xml.gz',\n",
       " 'pubmed21n0328.xml.gz',\n",
       " 'pubmed21n0329.xml.gz',\n",
       " 'pubmed21n0330.xml.gz',\n",
       " 'pubmed21n0331.xml.gz',\n",
       " 'pubmed21n0332.xml.gz',\n",
       " 'pubmed21n0333.xml.gz',\n",
       " 'pubmed21n0334.xml.gz',\n",
       " 'pubmed21n0335.xml.gz',\n",
       " 'pubmed21n0336.xml.gz',\n",
       " 'pubmed21n0337.xml.gz',\n",
       " 'pubmed21n0338.xml.gz',\n",
       " 'pubmed21n0339.xml.gz',\n",
       " 'pubmed21n0340.xml.gz',\n",
       " 'pubmed21n0341.xml.gz',\n",
       " 'pubmed21n0342.xml.gz',\n",
       " 'pubmed21n0343.xml.gz',\n",
       " 'pubmed21n0344.xml.gz',\n",
       " 'pubmed21n0345.xml.gz',\n",
       " 'pubmed21n0346.xml.gz',\n",
       " 'pubmed21n0347.xml.gz',\n",
       " 'pubmed21n0348.xml.gz',\n",
       " 'pubmed21n0349.xml.gz',\n",
       " 'pubmed21n0350.xml.gz',\n",
       " 'pubmed21n0351.xml.gz',\n",
       " 'pubmed21n0352.xml.gz',\n",
       " 'pubmed21n0353.xml.gz',\n",
       " 'pubmed21n0354.xml.gz',\n",
       " 'pubmed21n0355.xml.gz',\n",
       " 'pubmed21n0356.xml.gz',\n",
       " 'pubmed21n0357.xml.gz',\n",
       " 'pubmed21n0358.xml.gz',\n",
       " 'pubmed21n0359.xml.gz',\n",
       " 'pubmed21n0360.xml.gz',\n",
       " 'pubmed21n0361.xml.gz',\n",
       " 'pubmed21n0362.xml.gz',\n",
       " 'pubmed21n0363.xml.gz',\n",
       " 'pubmed21n0364.xml.gz',\n",
       " 'pubmed21n0365.xml.gz',\n",
       " 'pubmed21n0366.xml.gz',\n",
       " 'pubmed21n0367.xml.gz',\n",
       " 'pubmed21n0368.xml.gz',\n",
       " 'pubmed21n0369.xml.gz',\n",
       " 'pubmed21n0370.xml.gz',\n",
       " 'pubmed21n0371.xml.gz',\n",
       " 'pubmed21n0372.xml.gz',\n",
       " 'pubmed21n0373.xml.gz',\n",
       " 'pubmed21n0374.xml.gz',\n",
       " 'pubmed21n0375.xml.gz',\n",
       " 'pubmed21n0376.xml.gz',\n",
       " 'pubmed21n0377.xml.gz',\n",
       " 'pubmed21n0378.xml.gz',\n",
       " 'pubmed21n0379.xml.gz',\n",
       " 'pubmed21n0380.xml.gz',\n",
       " 'pubmed21n0381.xml.gz',\n",
       " 'pubmed21n0382.xml.gz',\n",
       " 'pubmed21n0383.xml.gz',\n",
       " 'pubmed21n0384.xml.gz',\n",
       " 'pubmed21n0385.xml.gz',\n",
       " 'pubmed21n0386.xml.gz',\n",
       " 'pubmed21n0387.xml.gz',\n",
       " 'pubmed21n0388.xml.gz',\n",
       " 'pubmed21n0389.xml.gz',\n",
       " 'pubmed21n0390.xml.gz',\n",
       " 'pubmed21n0391.xml.gz',\n",
       " 'pubmed21n0392.xml.gz',\n",
       " 'pubmed21n0393.xml.gz',\n",
       " 'pubmed21n0394.xml.gz',\n",
       " 'pubmed21n0395.xml.gz',\n",
       " 'pubmed21n0396.xml.gz',\n",
       " 'pubmed21n0397.xml.gz',\n",
       " 'pubmed21n0398.xml.gz',\n",
       " 'pubmed21n0399.xml.gz',\n",
       " 'pubmed21n0400.xml.gz',\n",
       " 'pubmed21n0401.xml.gz',\n",
       " 'pubmed21n0402.xml.gz',\n",
       " 'pubmed21n0403.xml.gz',\n",
       " 'pubmed21n0404.xml.gz',\n",
       " 'pubmed21n0405.xml.gz',\n",
       " 'pubmed21n0406.xml.gz',\n",
       " 'pubmed21n0407.xml.gz',\n",
       " 'pubmed21n0408.xml.gz',\n",
       " 'pubmed21n0409.xml.gz',\n",
       " 'pubmed21n0410.xml.gz',\n",
       " 'pubmed21n0411.xml.gz',\n",
       " 'pubmed21n0412.xml.gz',\n",
       " 'pubmed21n0413.xml.gz',\n",
       " 'pubmed21n0414.xml.gz',\n",
       " 'pubmed21n0415.xml.gz',\n",
       " 'pubmed21n0416.xml.gz',\n",
       " 'pubmed21n0417.xml.gz',\n",
       " 'pubmed21n0418.xml.gz',\n",
       " 'pubmed21n0419.xml.gz',\n",
       " 'pubmed21n0420.xml.gz',\n",
       " 'pubmed21n0421.xml.gz',\n",
       " 'pubmed21n0422.xml.gz',\n",
       " 'pubmed21n0423.xml.gz',\n",
       " 'pubmed21n0424.xml.gz',\n",
       " 'pubmed21n0425.xml.gz',\n",
       " 'pubmed21n0426.xml.gz',\n",
       " 'pubmed21n0427.xml.gz',\n",
       " 'pubmed21n0428.xml.gz',\n",
       " 'pubmed21n0429.xml.gz',\n",
       " 'pubmed21n0430.xml.gz',\n",
       " 'pubmed21n0431.xml.gz',\n",
       " 'pubmed21n0432.xml.gz',\n",
       " 'pubmed21n0433.xml.gz',\n",
       " 'pubmed21n0434.xml.gz',\n",
       " 'pubmed21n0435.xml.gz',\n",
       " 'pubmed21n0436.xml.gz',\n",
       " 'pubmed21n0437.xml.gz',\n",
       " 'pubmed21n0438.xml.gz',\n",
       " 'pubmed21n0439.xml.gz',\n",
       " 'pubmed21n0440.xml.gz',\n",
       " 'pubmed21n0441.xml.gz',\n",
       " 'pubmed21n0442.xml.gz',\n",
       " 'pubmed21n0443.xml.gz',\n",
       " 'pubmed21n0444.xml.gz',\n",
       " 'pubmed21n0445.xml.gz',\n",
       " 'pubmed21n0446.xml.gz',\n",
       " 'pubmed21n0447.xml.gz',\n",
       " 'pubmed21n0448.xml.gz',\n",
       " 'pubmed21n0449.xml.gz',\n",
       " 'pubmed21n0450.xml.gz',\n",
       " 'pubmed21n0451.xml.gz',\n",
       " 'pubmed21n0452.xml.gz',\n",
       " 'pubmed21n0453.xml.gz',\n",
       " 'pubmed21n0454.xml.gz',\n",
       " 'pubmed21n0455.xml.gz',\n",
       " 'pubmed21n0456.xml.gz',\n",
       " 'pubmed21n0457.xml.gz',\n",
       " 'pubmed21n0458.xml.gz',\n",
       " 'pubmed21n0459.xml.gz',\n",
       " 'pubmed21n0460.xml.gz',\n",
       " 'pubmed21n0461.xml.gz',\n",
       " 'pubmed21n0462.xml.gz',\n",
       " 'pubmed21n0463.xml.gz',\n",
       " 'pubmed21n0464.xml.gz',\n",
       " 'pubmed21n0465.xml.gz',\n",
       " 'pubmed21n0466.xml.gz',\n",
       " 'pubmed21n0467.xml.gz',\n",
       " 'pubmed21n0468.xml.gz',\n",
       " 'pubmed21n0469.xml.gz',\n",
       " 'pubmed21n0470.xml.gz',\n",
       " 'pubmed21n0471.xml.gz',\n",
       " 'pubmed21n0472.xml.gz',\n",
       " 'pubmed21n0473.xml.gz',\n",
       " 'pubmed21n0474.xml.gz',\n",
       " 'pubmed21n0475.xml.gz',\n",
       " 'pubmed21n0476.xml.gz',\n",
       " 'pubmed21n0477.xml.gz',\n",
       " 'pubmed21n0478.xml.gz',\n",
       " 'pubmed21n0479.xml.gz',\n",
       " 'pubmed21n0480.xml.gz',\n",
       " 'pubmed21n0481.xml.gz',\n",
       " 'pubmed21n0482.xml.gz',\n",
       " 'pubmed21n0483.xml.gz',\n",
       " 'pubmed21n0484.xml.gz',\n",
       " 'pubmed21n0485.xml.gz',\n",
       " 'pubmed21n0486.xml.gz',\n",
       " 'pubmed21n0487.xml.gz',\n",
       " 'pubmed21n0488.xml.gz',\n",
       " 'pubmed21n0489.xml.gz',\n",
       " 'pubmed21n0490.xml.gz',\n",
       " 'pubmed21n0491.xml.gz',\n",
       " 'pubmed21n0492.xml.gz',\n",
       " 'pubmed21n0493.xml.gz',\n",
       " 'pubmed21n0494.xml.gz',\n",
       " 'pubmed21n0495.xml.gz',\n",
       " 'pubmed21n0496.xml.gz',\n",
       " 'pubmed21n0497.xml.gz',\n",
       " 'pubmed21n0498.xml.gz',\n",
       " 'pubmed21n0499.xml.gz',\n",
       " 'pubmed21n0500.xml.gz',\n",
       " 'pubmed21n0501.xml.gz',\n",
       " 'pubmed21n0502.xml.gz',\n",
       " 'pubmed21n0503.xml.gz',\n",
       " 'pubmed21n0504.xml.gz',\n",
       " 'pubmed21n0505.xml.gz',\n",
       " 'pubmed21n0506.xml.gz',\n",
       " 'pubmed21n0507.xml.gz',\n",
       " 'pubmed21n0508.xml.gz',\n",
       " 'pubmed21n0509.xml.gz',\n",
       " 'pubmed21n0510.xml.gz',\n",
       " 'pubmed21n0511.xml.gz',\n",
       " 'pubmed21n0512.xml.gz',\n",
       " 'pubmed21n0513.xml.gz',\n",
       " 'pubmed21n0514.xml.gz',\n",
       " 'pubmed21n0515.xml.gz',\n",
       " 'pubmed21n0516.xml.gz',\n",
       " 'pubmed21n0517.xml.gz',\n",
       " 'pubmed21n0518.xml.gz',\n",
       " 'pubmed21n0519.xml.gz',\n",
       " 'pubmed21n0520.xml.gz',\n",
       " 'pubmed21n0521.xml.gz',\n",
       " 'pubmed21n0522.xml.gz',\n",
       " 'pubmed21n0523.xml.gz',\n",
       " 'pubmed21n0524.xml.gz',\n",
       " 'pubmed21n0525.xml.gz',\n",
       " 'pubmed21n0526.xml.gz',\n",
       " 'pubmed21n0527.xml.gz',\n",
       " 'pubmed21n0528.xml.gz',\n",
       " 'pubmed21n0529.xml.gz',\n",
       " 'pubmed21n0530.xml.gz',\n",
       " 'pubmed21n0531.xml.gz',\n",
       " 'pubmed21n0532.xml.gz',\n",
       " 'pubmed21n0533.xml.gz',\n",
       " 'pubmed21n0534.xml.gz',\n",
       " 'pubmed21n0535.xml.gz',\n",
       " 'pubmed21n0536.xml.gz',\n",
       " 'pubmed21n0537.xml.gz',\n",
       " 'pubmed21n0538.xml.gz',\n",
       " 'pubmed21n0539.xml.gz',\n",
       " 'pubmed21n0540.xml.gz',\n",
       " 'pubmed21n0541.xml.gz',\n",
       " 'pubmed21n0542.xml.gz',\n",
       " 'pubmed21n0543.xml.gz',\n",
       " 'pubmed21n0544.xml.gz',\n",
       " 'pubmed21n0545.xml.gz',\n",
       " 'pubmed21n0546.xml.gz',\n",
       " 'pubmed21n0547.xml.gz',\n",
       " 'pubmed21n0548.xml.gz',\n",
       " 'pubmed21n0549.xml.gz',\n",
       " 'pubmed21n0550.xml.gz',\n",
       " 'pubmed21n0551.xml.gz',\n",
       " 'pubmed21n0552.xml.gz',\n",
       " 'pubmed21n0553.xml.gz',\n",
       " 'pubmed21n0554.xml.gz',\n",
       " 'pubmed21n0555.xml.gz',\n",
       " 'pubmed21n0556.xml.gz',\n",
       " 'pubmed21n0557.xml.gz',\n",
       " 'pubmed21n0558.xml.gz',\n",
       " 'pubmed21n0559.xml.gz',\n",
       " 'pubmed21n0560.xml.gz',\n",
       " 'pubmed21n0561.xml.gz',\n",
       " 'pubmed21n0562.xml.gz',\n",
       " 'pubmed21n0563.xml.gz',\n",
       " 'pubmed21n0564.xml.gz',\n",
       " 'pubmed21n0565.xml.gz',\n",
       " 'pubmed21n0566.xml.gz',\n",
       " 'pubmed21n0567.xml.gz',\n",
       " 'pubmed21n0568.xml.gz',\n",
       " 'pubmed21n0569.xml.gz',\n",
       " 'pubmed21n0570.xml.gz',\n",
       " 'pubmed21n0571.xml.gz',\n",
       " 'pubmed21n0572.xml.gz',\n",
       " 'pubmed21n0573.xml.gz',\n",
       " 'pubmed21n0574.xml.gz',\n",
       " 'pubmed21n0575.xml.gz',\n",
       " 'pubmed21n0576.xml.gz',\n",
       " 'pubmed21n0577.xml.gz',\n",
       " 'pubmed21n0578.xml.gz',\n",
       " 'pubmed21n0579.xml.gz',\n",
       " 'pubmed21n0580.xml.gz',\n",
       " 'pubmed21n0581.xml.gz',\n",
       " 'pubmed21n0582.xml.gz',\n",
       " 'pubmed21n0583.xml.gz',\n",
       " 'pubmed21n0584.xml.gz',\n",
       " 'pubmed21n0585.xml.gz',\n",
       " 'pubmed21n0586.xml.gz',\n",
       " 'pubmed21n0587.xml.gz',\n",
       " 'pubmed21n0588.xml.gz',\n",
       " 'pubmed21n0589.xml.gz',\n",
       " 'pubmed21n0590.xml.gz',\n",
       " 'pubmed21n0591.xml.gz',\n",
       " 'pubmed21n0592.xml.gz',\n",
       " 'pubmed21n0593.xml.gz',\n",
       " 'pubmed21n0594.xml.gz',\n",
       " 'pubmed21n0595.xml.gz',\n",
       " 'pubmed21n0596.xml.gz',\n",
       " 'pubmed21n0597.xml.gz',\n",
       " 'pubmed21n0598.xml.gz',\n",
       " 'pubmed21n0599.xml.gz',\n",
       " 'pubmed21n0600.xml.gz',\n",
       " 'pubmed21n0601.xml.gz',\n",
       " 'pubmed21n0602.xml.gz',\n",
       " 'pubmed21n0603.xml.gz',\n",
       " 'pubmed21n0604.xml.gz',\n",
       " 'pubmed21n0605.xml.gz',\n",
       " 'pubmed21n0606.xml.gz',\n",
       " 'pubmed21n0607.xml.gz',\n",
       " 'pubmed21n0608.xml.gz',\n",
       " 'pubmed21n0609.xml.gz',\n",
       " 'pubmed21n0610.xml.gz',\n",
       " 'pubmed21n0611.xml.gz',\n",
       " 'pubmed21n0612.xml.gz',\n",
       " 'pubmed21n0613.xml.gz',\n",
       " 'pubmed21n0614.xml.gz',\n",
       " 'pubmed21n0615.xml.gz',\n",
       " 'pubmed21n0616.xml.gz',\n",
       " 'pubmed21n0617.xml.gz',\n",
       " 'pubmed21n0618.xml.gz',\n",
       " 'pubmed21n0619.xml.gz',\n",
       " 'pubmed21n0620.xml.gz',\n",
       " 'pubmed21n0621.xml.gz',\n",
       " 'pubmed21n0622.xml.gz',\n",
       " 'pubmed21n0623.xml.gz',\n",
       " 'pubmed21n0624.xml.gz',\n",
       " 'pubmed21n0625.xml.gz',\n",
       " 'pubmed21n0626.xml.gz',\n",
       " 'pubmed21n0627.xml.gz',\n",
       " 'pubmed21n0628.xml.gz',\n",
       " 'pubmed21n0629.xml.gz',\n",
       " 'pubmed21n0630.xml.gz',\n",
       " 'pubmed21n0631.xml.gz',\n",
       " 'pubmed21n0632.xml.gz',\n",
       " 'pubmed21n0633.xml.gz',\n",
       " 'pubmed21n0634.xml.gz',\n",
       " 'pubmed21n0635.xml.gz',\n",
       " 'pubmed21n0636.xml.gz',\n",
       " 'pubmed21n0637.xml.gz',\n",
       " 'pubmed21n0638.xml.gz',\n",
       " 'pubmed21n0639.xml.gz',\n",
       " 'pubmed21n0640.xml.gz',\n",
       " 'pubmed21n0641.xml.gz',\n",
       " 'pubmed21n0642.xml.gz',\n",
       " 'pubmed21n0643.xml.gz',\n",
       " 'pubmed21n0644.xml.gz',\n",
       " 'pubmed21n0645.xml.gz',\n",
       " 'pubmed21n0646.xml.gz',\n",
       " 'pubmed21n0647.xml.gz',\n",
       " 'pubmed21n0648.xml.gz',\n",
       " 'pubmed21n0649.xml.gz',\n",
       " 'pubmed21n0650.xml.gz',\n",
       " 'pubmed21n0651.xml.gz',\n",
       " 'pubmed21n0652.xml.gz',\n",
       " 'pubmed21n0653.xml.gz',\n",
       " 'pubmed21n0654.xml.gz',\n",
       " 'pubmed21n0655.xml.gz',\n",
       " 'pubmed21n0656.xml.gz',\n",
       " 'pubmed21n0657.xml.gz',\n",
       " 'pubmed21n0658.xml.gz',\n",
       " 'pubmed21n0659.xml.gz',\n",
       " 'pubmed21n0660.xml.gz',\n",
       " 'pubmed21n0661.xml.gz',\n",
       " 'pubmed21n0662.xml.gz',\n",
       " 'pubmed21n0663.xml.gz',\n",
       " 'pubmed21n0664.xml.gz',\n",
       " 'pubmed21n0665.xml.gz',\n",
       " 'pubmed21n0666.xml.gz',\n",
       " 'pubmed21n0667.xml.gz',\n",
       " 'pubmed21n0668.xml.gz',\n",
       " 'pubmed21n0669.xml.gz',\n",
       " 'pubmed21n0670.xml.gz',\n",
       " 'pubmed21n0671.xml.gz',\n",
       " 'pubmed21n0672.xml.gz',\n",
       " 'pubmed21n0673.xml.gz',\n",
       " 'pubmed21n0674.xml.gz',\n",
       " 'pubmed21n0675.xml.gz',\n",
       " 'pubmed21n0676.xml.gz',\n",
       " 'pubmed21n0677.xml.gz',\n",
       " 'pubmed21n0678.xml.gz',\n",
       " 'pubmed21n0679.xml.gz',\n",
       " 'pubmed21n0680.xml.gz',\n",
       " 'pubmed21n0681.xml.gz',\n",
       " 'pubmed21n0682.xml.gz',\n",
       " 'pubmed21n0683.xml.gz',\n",
       " 'pubmed21n0684.xml.gz',\n",
       " 'pubmed21n0685.xml.gz',\n",
       " 'pubmed21n0686.xml.gz',\n",
       " 'pubmed21n0687.xml.gz',\n",
       " 'pubmed21n0688.xml.gz',\n",
       " 'pubmed21n0689.xml.gz',\n",
       " 'pubmed21n0690.xml.gz',\n",
       " 'pubmed21n0691.xml.gz',\n",
       " 'pubmed21n0692.xml.gz',\n",
       " 'pubmed21n0693.xml.gz',\n",
       " 'pubmed21n0694.xml.gz',\n",
       " 'pubmed21n0695.xml.gz',\n",
       " 'pubmed21n0696.xml.gz',\n",
       " 'pubmed21n0697.xml.gz',\n",
       " 'pubmed21n0698.xml.gz',\n",
       " 'pubmed21n0699.xml.gz',\n",
       " 'pubmed21n0700.xml.gz',\n",
       " 'pubmed21n0701.xml.gz',\n",
       " 'pubmed21n0702.xml.gz',\n",
       " 'pubmed21n0703.xml.gz',\n",
       " 'pubmed21n0704.xml.gz',\n",
       " 'pubmed21n0705.xml.gz',\n",
       " 'pubmed21n0706.xml.gz',\n",
       " 'pubmed21n0707.xml.gz',\n",
       " 'pubmed21n0708.xml.gz',\n",
       " 'pubmed21n0709.xml.gz',\n",
       " 'pubmed21n0710.xml.gz',\n",
       " 'pubmed21n0711.xml.gz',\n",
       " 'pubmed21n0712.xml.gz',\n",
       " 'pubmed21n0713.xml.gz',\n",
       " 'pubmed21n0714.xml.gz',\n",
       " 'pubmed21n0715.xml.gz',\n",
       " 'pubmed21n0716.xml.gz',\n",
       " 'pubmed21n0717.xml.gz',\n",
       " 'pubmed21n0718.xml.gz',\n",
       " 'pubmed21n0719.xml.gz',\n",
       " 'pubmed21n0720.xml.gz',\n",
       " 'pubmed21n0721.xml.gz',\n",
       " 'pubmed21n0722.xml.gz',\n",
       " 'pubmed21n0723.xml.gz',\n",
       " 'pubmed21n0724.xml.gz',\n",
       " 'pubmed21n0725.xml.gz',\n",
       " 'pubmed21n0726.xml.gz',\n",
       " 'pubmed21n0727.xml.gz',\n",
       " 'pubmed21n0728.xml.gz',\n",
       " 'pubmed21n0729.xml.gz',\n",
       " 'pubmed21n0730.xml.gz',\n",
       " 'pubmed21n0731.xml.gz',\n",
       " 'pubmed21n0732.xml.gz',\n",
       " 'pubmed21n0733.xml.gz',\n",
       " 'pubmed21n0734.xml.gz',\n",
       " 'pubmed21n0735.xml.gz',\n",
       " 'pubmed21n0736.xml.gz',\n",
       " 'pubmed21n0737.xml.gz',\n",
       " 'pubmed21n0738.xml.gz',\n",
       " 'pubmed21n0739.xml.gz',\n",
       " 'pubmed21n0740.xml.gz',\n",
       " 'pubmed21n0741.xml.gz',\n",
       " 'pubmed21n0742.xml.gz',\n",
       " 'pubmed21n0743.xml.gz',\n",
       " 'pubmed21n0744.xml.gz',\n",
       " 'pubmed21n0745.xml.gz',\n",
       " 'pubmed21n0746.xml.gz',\n",
       " 'pubmed21n0747.xml.gz',\n",
       " 'pubmed21n0748.xml.gz',\n",
       " 'pubmed21n0749.xml.gz',\n",
       " 'pubmed21n0750.xml.gz',\n",
       " 'pubmed21n0751.xml.gz',\n",
       " 'pubmed21n0752.xml.gz',\n",
       " 'pubmed21n0753.xml.gz',\n",
       " 'pubmed21n0754.xml.gz',\n",
       " 'pubmed21n0755.xml.gz',\n",
       " 'pubmed21n0756.xml.gz',\n",
       " 'pubmed21n0757.xml.gz',\n",
       " 'pubmed21n0758.xml.gz',\n",
       " 'pubmed21n0759.xml.gz',\n",
       " 'pubmed21n0760.xml.gz',\n",
       " 'pubmed21n0761.xml.gz',\n",
       " 'pubmed21n0762.xml.gz',\n",
       " 'pubmed21n0763.xml.gz',\n",
       " 'pubmed21n0764.xml.gz',\n",
       " 'pubmed21n0765.xml.gz',\n",
       " 'pubmed21n0766.xml.gz',\n",
       " 'pubmed21n0767.xml.gz',\n",
       " 'pubmed21n0768.xml.gz',\n",
       " 'pubmed21n0769.xml.gz',\n",
       " 'pubmed21n0770.xml.gz',\n",
       " 'pubmed21n0771.xml.gz',\n",
       " 'pubmed21n0772.xml.gz',\n",
       " 'pubmed21n0773.xml.gz',\n",
       " 'pubmed21n0774.xml.gz',\n",
       " 'pubmed21n0775.xml.gz',\n",
       " 'pubmed21n0776.xml.gz',\n",
       " 'pubmed21n0777.xml.gz',\n",
       " 'pubmed21n0778.xml.gz',\n",
       " 'pubmed21n0779.xml.gz',\n",
       " 'pubmed21n0780.xml.gz',\n",
       " 'pubmed21n0781.xml.gz',\n",
       " 'pubmed21n0782.xml.gz',\n",
       " 'pubmed21n0783.xml.gz',\n",
       " 'pubmed21n0784.xml.gz',\n",
       " 'pubmed21n0785.xml.gz',\n",
       " 'pubmed21n0786.xml.gz',\n",
       " 'pubmed21n0787.xml.gz',\n",
       " 'pubmed21n0788.xml.gz',\n",
       " 'pubmed21n0789.xml.gz',\n",
       " 'pubmed21n0790.xml.gz',\n",
       " 'pubmed21n0791.xml.gz',\n",
       " 'pubmed21n0792.xml.gz',\n",
       " 'pubmed21n0793.xml.gz',\n",
       " 'pubmed21n0794.xml.gz',\n",
       " 'pubmed21n0795.xml.gz',\n",
       " 'pubmed21n0796.xml.gz',\n",
       " 'pubmed21n0797.xml.gz',\n",
       " 'pubmed21n0798.xml.gz',\n",
       " 'pubmed21n0799.xml.gz',\n",
       " 'pubmed21n0800.xml.gz',\n",
       " 'pubmed21n0801.xml.gz',\n",
       " 'pubmed21n0802.xml.gz',\n",
       " 'pubmed21n0803.xml.gz',\n",
       " 'pubmed21n0804.xml.gz',\n",
       " 'pubmed21n0805.xml.gz',\n",
       " 'pubmed21n0806.xml.gz',\n",
       " 'pubmed21n0807.xml.gz',\n",
       " 'pubmed21n0808.xml.gz',\n",
       " 'pubmed21n0809.xml.gz',\n",
       " 'pubmed21n0810.xml.gz',\n",
       " 'pubmed21n0811.xml.gz',\n",
       " 'pubmed21n0812.xml.gz',\n",
       " 'pubmed21n0813.xml.gz',\n",
       " 'pubmed21n0814.xml.gz',\n",
       " 'pubmed21n0815.xml.gz',\n",
       " 'pubmed21n0816.xml.gz',\n",
       " 'pubmed21n0817.xml.gz',\n",
       " 'pubmed21n0818.xml.gz',\n",
       " 'pubmed21n0819.xml.gz',\n",
       " 'pubmed21n0820.xml.gz',\n",
       " 'pubmed21n0821.xml.gz',\n",
       " 'pubmed21n0822.xml.gz',\n",
       " 'pubmed21n0823.xml.gz',\n",
       " 'pubmed21n0824.xml.gz',\n",
       " 'pubmed21n0825.xml.gz',\n",
       " 'pubmed21n0826.xml.gz',\n",
       " 'pubmed21n0827.xml.gz',\n",
       " 'pubmed21n0828.xml.gz',\n",
       " 'pubmed21n0829.xml.gz',\n",
       " 'pubmed21n0830.xml.gz',\n",
       " 'pubmed21n0831.xml.gz',\n",
       " 'pubmed21n0832.xml.gz',\n",
       " 'pubmed21n0833.xml.gz',\n",
       " 'pubmed21n0834.xml.gz',\n",
       " 'pubmed21n0835.xml.gz',\n",
       " 'pubmed21n0836.xml.gz',\n",
       " 'pubmed21n0837.xml.gz',\n",
       " 'pubmed21n0838.xml.gz',\n",
       " 'pubmed21n0839.xml.gz',\n",
       " 'pubmed21n0840.xml.gz',\n",
       " 'pubmed21n0841.xml.gz',\n",
       " 'pubmed21n0842.xml.gz',\n",
       " 'pubmed21n0843.xml.gz',\n",
       " 'pubmed21n0844.xml.gz',\n",
       " 'pubmed21n0845.xml.gz',\n",
       " 'pubmed21n0846.xml.gz',\n",
       " 'pubmed21n0847.xml.gz',\n",
       " 'pubmed21n0848.xml.gz',\n",
       " 'pubmed21n0849.xml.gz',\n",
       " 'pubmed21n0850.xml.gz',\n",
       " 'pubmed21n0851.xml.gz',\n",
       " 'pubmed21n0852.xml.gz',\n",
       " 'pubmed21n0853.xml.gz',\n",
       " 'pubmed21n0854.xml.gz',\n",
       " 'pubmed21n0855.xml.gz',\n",
       " 'pubmed21n0856.xml.gz',\n",
       " 'pubmed21n0857.xml.gz',\n",
       " 'pubmed21n0858.xml.gz',\n",
       " 'pubmed21n0859.xml.gz',\n",
       " 'pubmed21n0860.xml.gz',\n",
       " 'pubmed21n0861.xml.gz',\n",
       " 'pubmed21n0862.xml.gz',\n",
       " 'pubmed21n0863.xml.gz',\n",
       " 'pubmed21n0864.xml.gz',\n",
       " 'pubmed21n0865.xml.gz',\n",
       " 'pubmed21n0866.xml.gz',\n",
       " 'pubmed21n0867.xml.gz',\n",
       " 'pubmed21n0868.xml.gz',\n",
       " 'pubmed21n0869.xml.gz',\n",
       " 'pubmed21n0870.xml.gz',\n",
       " 'pubmed21n0871.xml.gz',\n",
       " 'pubmed21n0872.xml.gz',\n",
       " 'pubmed21n0873.xml.gz',\n",
       " 'pubmed21n0874.xml.gz',\n",
       " 'pubmed21n0875.xml.gz',\n",
       " 'pubmed21n0876.xml.gz',\n",
       " 'pubmed21n0877.xml.gz',\n",
       " 'pubmed21n0878.xml.gz',\n",
       " 'pubmed21n0879.xml.gz',\n",
       " 'pubmed21n0880.xml.gz',\n",
       " 'pubmed21n0881.xml.gz',\n",
       " 'pubmed21n0882.xml.gz',\n",
       " 'pubmed21n0883.xml.gz',\n",
       " 'pubmed21n0884.xml.gz',\n",
       " 'pubmed21n0885.xml.gz',\n",
       " 'pubmed21n0886.xml.gz',\n",
       " 'pubmed21n0887.xml.gz',\n",
       " 'pubmed21n0888.xml.gz',\n",
       " 'pubmed21n0889.xml.gz',\n",
       " 'pubmed21n0890.xml.gz',\n",
       " 'pubmed21n0891.xml.gz',\n",
       " 'pubmed21n0892.xml.gz',\n",
       " 'pubmed21n0893.xml.gz',\n",
       " 'pubmed21n0894.xml.gz',\n",
       " 'pubmed21n0895.xml.gz',\n",
       " 'pubmed21n0896.xml.gz',\n",
       " 'pubmed21n0897.xml.gz',\n",
       " 'pubmed21n0898.xml.gz',\n",
       " 'pubmed21n0899.xml.gz',\n",
       " 'pubmed21n0900.xml.gz',\n",
       " 'pubmed21n0901.xml.gz',\n",
       " 'pubmed21n0902.xml.gz',\n",
       " 'pubmed21n0903.xml.gz',\n",
       " 'pubmed21n0904.xml.gz',\n",
       " 'pubmed21n0905.xml.gz',\n",
       " 'pubmed21n0906.xml.gz',\n",
       " 'pubmed21n0907.xml.gz',\n",
       " 'pubmed21n0908.xml.gz',\n",
       " 'pubmed21n0909.xml.gz',\n",
       " 'pubmed21n0910.xml.gz',\n",
       " 'pubmed21n0911.xml.gz',\n",
       " 'pubmed21n0912.xml.gz',\n",
       " 'pubmed21n0913.xml.gz',\n",
       " 'pubmed21n0914.xml.gz',\n",
       " 'pubmed21n0915.xml.gz',\n",
       " 'pubmed21n0916.xml.gz',\n",
       " 'pubmed21n0917.xml.gz',\n",
       " 'pubmed21n0918.xml.gz',\n",
       " 'pubmed21n0919.xml.gz',\n",
       " 'pubmed21n0920.xml.gz',\n",
       " 'pubmed21n0921.xml.gz',\n",
       " 'pubmed21n0922.xml.gz',\n",
       " 'pubmed21n0923.xml.gz',\n",
       " 'pubmed21n0924.xml.gz',\n",
       " 'pubmed21n0925.xml.gz',\n",
       " 'pubmed21n0926.xml.gz',\n",
       " 'pubmed21n0927.xml.gz',\n",
       " 'pubmed21n0928.xml.gz',\n",
       " 'pubmed21n0929.xml.gz',\n",
       " 'pubmed21n0930.xml.gz',\n",
       " 'pubmed21n0931.xml.gz',\n",
       " 'pubmed21n0932.xml.gz',\n",
       " 'pubmed21n0933.xml.gz',\n",
       " 'pubmed21n0934.xml.gz',\n",
       " 'pubmed21n0935.xml.gz',\n",
       " 'pubmed21n0936.xml.gz',\n",
       " 'pubmed21n0937.xml.gz',\n",
       " 'pubmed21n0938.xml.gz',\n",
       " 'pubmed21n0939.xml.gz',\n",
       " 'pubmed21n0940.xml.gz',\n",
       " 'pubmed21n0941.xml.gz',\n",
       " 'pubmed21n0942.xml.gz',\n",
       " 'pubmed21n0943.xml.gz',\n",
       " 'pubmed21n0944.xml.gz',\n",
       " 'pubmed21n0945.xml.gz',\n",
       " 'pubmed21n0946.xml.gz',\n",
       " 'pubmed21n0947.xml.gz',\n",
       " 'pubmed21n0948.xml.gz',\n",
       " 'pubmed21n0949.xml.gz',\n",
       " 'pubmed21n0950.xml.gz',\n",
       " 'pubmed21n0951.xml.gz',\n",
       " 'pubmed21n0952.xml.gz',\n",
       " 'pubmed21n0953.xml.gz',\n",
       " 'pubmed21n0954.xml.gz',\n",
       " 'pubmed21n0955.xml.gz',\n",
       " 'pubmed21n0956.xml.gz',\n",
       " 'pubmed21n0957.xml.gz',\n",
       " 'pubmed21n0958.xml.gz',\n",
       " 'pubmed21n0959.xml.gz',\n",
       " 'pubmed21n0960.xml.gz',\n",
       " 'pubmed21n0961.xml.gz',\n",
       " 'pubmed21n0962.xml.gz',\n",
       " 'pubmed21n0963.xml.gz',\n",
       " 'pubmed21n0964.xml.gz',\n",
       " 'pubmed21n0965.xml.gz',\n",
       " 'pubmed21n0966.xml.gz',\n",
       " 'pubmed21n0967.xml.gz',\n",
       " 'pubmed21n0968.xml.gz',\n",
       " 'pubmed21n0969.xml.gz',\n",
       " 'pubmed21n0970.xml.gz',\n",
       " 'pubmed21n0971.xml.gz',\n",
       " 'pubmed21n0972.xml.gz',\n",
       " 'pubmed21n0973.xml.gz',\n",
       " 'pubmed21n0974.xml.gz',\n",
       " 'pubmed21n0975.xml.gz',\n",
       " 'pubmed21n0976.xml.gz',\n",
       " 'pubmed21n0977.xml.gz',\n",
       " 'pubmed21n0978.xml.gz',\n",
       " 'pubmed21n0979.xml.gz',\n",
       " 'pubmed21n0980.xml.gz',\n",
       " 'pubmed21n0981.xml.gz',\n",
       " 'pubmed21n0982.xml.gz',\n",
       " 'pubmed21n0983.xml.gz',\n",
       " 'pubmed21n0984.xml.gz',\n",
       " 'pubmed21n0985.xml.gz',\n",
       " 'pubmed21n0986.xml.gz',\n",
       " 'pubmed21n0987.xml.gz',\n",
       " 'pubmed21n0988.xml.gz',\n",
       " 'pubmed21n0989.xml.gz',\n",
       " 'pubmed21n0990.xml.gz',\n",
       " 'pubmed21n0991.xml.gz',\n",
       " 'pubmed21n0992.xml.gz',\n",
       " 'pubmed21n0993.xml.gz',\n",
       " 'pubmed21n0994.xml.gz',\n",
       " 'pubmed21n0995.xml.gz',\n",
       " 'pubmed21n0996.xml.gz',\n",
       " 'pubmed21n0997.xml.gz',\n",
       " 'pubmed21n0998.xml.gz',\n",
       " 'pubmed21n0999.xml.gz',\n",
       " 'pubmed21n1000.xml.gz',\n",
       " ...]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pubmed_files=list\n",
    "pubmed_files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "empty=[]\n",
    "for i in range(0,250):\n",
    "    a123=pp.parse_medline_xml(pubmed_files[i])\n",
    "    for j in range(len(a123)):\n",
    "        line=a123[j]['mesh_terms']\n",
    "        line=line.lower()\n",
    "        if line.find('patient compliance')!= -1:\n",
    "            empty.append(a123[j])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "empty1=[]\n",
    "for i in range(250,500):\n",
    "    a123=pp.parse_medline_xml(pubmed_files[i])\n",
    "    for j in range(len(a123)):\n",
    "        line=a123[j]['mesh_terms']\n",
    "        line=line.lower()\n",
    "        if line.find('patient compliance')!= -1:\n",
    "            empty1.append(a123[j])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "empty2=[]\n",
    "for i in range(500,750):\n",
    "    a123=pp.parse_medline_xml(pubmed_files[i])\n",
    "    for j in range(len(a123)):\n",
    "        line=a123[j]['mesh_terms']\n",
    "        line=line.lower()\n",
    "        if line.find('patient compliance')!= -1:\n",
    "            empty2.append(a123[j])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "empty3=[]\n",
    "for i in range(750,1062):\n",
    "    a123=pp.parse_medline_xml(pubmed_files[i])\n",
    "    for j in range(len(a123)):\n",
    "        line=a123[j]['mesh_terms']\n",
    "        line=line.lower()\n",
    "        if line.find('patient compliance')!= -1:\n",
    "            empty3.append(a123[j])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Polypsychopharmacy.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Bulletin of the Menninger Clinic',\n",
       "  'authors': 'S Sturges;M Brown',\n",
       "  'pubdate': '1975',\n",
       "  'pmid': '110',\n",
       "  'mesh_terms': 'D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D004359:Drug Therapy, Combination; D006801:Humans; D001523:Mental Disorders; D010349:Patient Compliance; D011567:Psychiatric Department, Hospital; D011600:Psychopharmacology',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000978:Antiparkinson Agents; D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '15790987;16284219;17287242;17714991;19052045;20435867',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Bull Menninger Clin',\n",
       "  'nlm_unique_id': '7507032',\n",
       "  'issn_linking': '0025-9284',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Impact of psychosocial factors on the conduct of combined drug and psychotherapy research.',\n",
       "  'abstract': \"The effect of attitudes of therapists, patients and researchers on the conduct and outcome of combined drug and psychotherapy research was examined in a brief crisis-oriented psychotherapy clinic. Seventy-seven consecutive patients were given one of two anti-anxiety drugs or a placebo in conjunction with the typical psychoanalytically-oriented treatment used in the clinic. The therapists' attitudes favouring psychotherapy over drug therapy (and psychotherapy research) were clearly conveyed to the patients. Indicative of this are the following: (a) 82 per cent of the patients dropped out of drug taking, although a similar percentage remained in treatment; (b) only a third of the patients perceived it as being important to their therapists that they should take medication; (c) 87 per cent of the patients were rated as improved; and 75 per cent of patients completing forms considered that most or all of their improvement was attributable to talking. The research team, made up of members of the same department who therefore had similar values as the therapists, diligently collected outcome data, but ignored its responsibility to enforce drug-relation portions of the protocol. Overall, patients remained in therapy, improved and participated in completing forms, so that only the research goals of combined therapy were thwarted, while traditional clinic service and training goals proceeded as usual.\",\n",
       "  'journal': 'The British journal of psychiatry : the journal of mental science',\n",
       "  'authors': 'WN Stone;BL Green;GC Gleser;RM Whitman;BB Foster',\n",
       "  'pubdate': '1975',\n",
       "  'pmid': '1135',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D003258:Consumer Behavior; D003419:Crisis Intervention; D005260:Female; D006801:Humans; D007396:Internship and Residency; D007400:Interprofessional Relations; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011575:Psychoanalytic Therapy; D012107:Research Design; D012659:Semantic Differential',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1192/bjp.127.5.432',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Psychiatry',\n",
       "  'nlm_unique_id': '0342367',\n",
       "  'issn_linking': '0007-1250',\n",
       "  'country': 'England'},\n",
       " {'title': 'The expectation of outcome from maintenance therapy in chronic schizophrenic patients.',\n",
       "  'abstract': 'The results from a prospective follow-up study of a group of schizophrenic patients suggest that a significant proportion (41 per cent) are likely to relapse during a two-year period despite the prescription of long-acting injectable neuroleptic drugs. Some will relapse because of a failure of the regime, but others (32-37 per cent) because the pharmacological protection of these drugs would appear to be less effective in certain patients. Even with the major advantages of the long-acting injectable neuroleptics over oral medication, the schizophrenic patient population remains a group with a high incidence of psychiatric and social morbidity which continues to require the full resources of both the hospital and community services.',\n",
       "  'journal': 'The British journal of psychiatry : the journal of mental science',\n",
       "  'authors': 'DA Johnson',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '3251',\n",
       "  'mesh_terms': 'D010054:Brief Psychiatric Rating Scale; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D006801:Humans; D010349:Patient Compliance; D010352:Patient Dropouts; D010359:Patient Readmission; D011446:Prospective Studies; D012008:Recurrence; D012559:Schizophrenia; D012917:Social Adjustment; D013997:Time Factors; D014149:Tranquilizing Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003692:Delayed-Action Preparations; D014149:Tranquilizing Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1192/bjp.128.3.246',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Psychiatry',\n",
       "  'nlm_unique_id': '0342367',\n",
       "  'issn_linking': '0007-1250',\n",
       "  'country': 'England'},\n",
       " {'title': 'The current status of behavioral psychotherapy: theory and practice.',\n",
       "  'abstract': 'Behavioral psychotherapy has become one of the definitive treatments available for the relief of psychiatric suffering. Although hardly a panacea for all ills, the behavioral approach is the treatment of choice for certain selected problems. Behavioral methods make their contribution in the context of general psychiatric management and often must be used in conjunction with other treatment. The theoretical and practical aspects of behavioral psychotherapy have changed a great deal over the past few years and continue to evolve rapidly. Although useful molecular theories are emerging to guide the discipline, no global theory is likely to be satisfactory in the foreseeable future.',\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'IM Marks',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '3978',\n",
       "  'mesh_terms': 'D001007:Anxiety; D001521:Behavior Therapy; D003192:Compulsive Behavior; D003887:Desensitization, Psychologic; D006185:Habituation, Psychophysiologic; D006801:Humans; D009042:Motivation; D010349:Patient Compliance; D010698:Phobic Disorders; D011582:Psychological Theory; D009626:Terminology as Topic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.133.3.253',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Vasodilator administration in the presence of beta-adrenergic blockade.',\n",
       "  'abstract': 'To explore the possibility that the presence of propranolol-induced beta-adrenergic blockade might have an adverse effect upon homeostatic circulatory reflexes activated by the administration of a potent vasodilator agent, arterial blood pressure and pulse rate response to rapid intravenous diazoxide injection was monitored before and after pretreatment with propranolol in ten hypertensive patients. It appeared that beta-adrenergic blockade had no clinically significant effect on the magnitude of hypotension or the degree of heart rate acceleration induced by the administration of the potent vasodilator diazoxide. This reflex vasodilator-induced cardio-acceleration after propranolol adminstration could be the result of incomplete blockade of endogenously released neurotransmitter, inhibition of the parasympathetic nervous system, or a direct pharmacologic action of diazoxide. Diazoxide administration to hypertensive patients in the presence of beta-adrenergic blockade was not associated with any clinically significant hemodynamic consequences.',\n",
       "  'journal': 'Circulation',\n",
       "  'authors': 'WJ Mroczek;WR Lee;ME Davidov;FA Finnerty',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '5209',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists; D000328:Adult; D001794:Blood Pressure; D002319:Cardiovascular System; D003981:Diazoxide; D004347:Drug Interactions; D005260:Female; D006339:Heart Rate; D006439:Hemodynamics; D006805:Human Experimentation; D006801:Humans; D006973:Hypertension; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011292:Premedication; D011433:Propranolol; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011433:Propranolol; D003981:Diazoxide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.cir.53.6.985',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Circulation',\n",
       "  'nlm_unique_id': '0147763',\n",
       "  'issn_linking': '0009-7322',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Camazepam (SB/5833) in preparation for endoscopy inspection: open and double-blind study versus diazepam.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current therapeutic research, clinical and experimental',\n",
       "  'authors': 'G Galli',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '5249',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D002219:Carbamates; D002986:Clinical Trials as Topic; D003975:Diazepam; D004724:Endoscopy; D006801:Humans; D010349:Patient Compliance; D012018:Reflex',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D002219:Carbamates; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Ther Res Clin Exp',\n",
       "  'nlm_unique_id': '0372621',\n",
       "  'issn_linking': '0011-393X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Assessment of drugs in schizophrenia. Basic trial design.',\n",
       "  'abstract': 'Clinical trials with major tranquilizers must take into account the clinical features of patients with schizophrenia and pharmacokinetic and pharmacodynamic properties of the drug. The objectives of the trial must be carefully defined so that appropriate selection criteria for patients, rating instruments and dosage schedules can be selected. It is useful to monitor physiological and biochemical actions of major tranquilizers as well as the clinical effects.',\n",
       "  'journal': 'British journal of clinical pharmacology',\n",
       "  'authors': 'M Lader',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '9964',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004347:Drug Interactions; D006801:Humans; D010349:Patient Compliance; D012008:Recurrence; D012107:Research Design; D012559:Schizophrenia; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2125.1976.tb03728.x',\n",
       "  'references': '13730891;4577254;4584708;4692493;4715848;4936538;5014628;5017376;5081606;5335182',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Clin Pharmacol',\n",
       "  'nlm_unique_id': '7503323',\n",
       "  'issn_linking': '0306-5251',\n",
       "  'country': 'England'},\n",
       " {'title': 'Some effects of reduction in reinforcement magnitude in a monetary economy with hospitalized alcoholics.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Behaviour research and therapy',\n",
       "  'authors': 'LJ Boggs;V Rozynko;GA Flint',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '11769',\n",
       "  'mesh_terms': 'D000328:Adult; D000437:Alcoholism; D003887:Desensitization, Psychologic; D005260:Female; D006760:Hospitalization; D006801:Humans; D007206:Individuality; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012201:Reward',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0005-7967(76)90092-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Behav Res Ther',\n",
       "  'nlm_unique_id': '0372477',\n",
       "  'issn_linking': '0005-7967',\n",
       "  'country': 'England'},\n",
       " {'title': 'Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension.',\n",
       "  'abstract': \"Fifty-five patients with mild to moderate, renal or essential hypertension were admitted to a double blind cross-over trial of 18 weeks, involving treatment periods with placebo, the thiazide bendrofluazide (15 mg daily) and the beta blocker atenolol (600 mg daily). Compared to the placebo period (190/117 mm Hg) the hypotensive effect of atenolol (-24/16 mm Hg) was more pronounced than the hypotensive effect of bendrofluazide (-17/6 mm Hg). Arguments in favor of initiating antihypertensive drug therapy with beta blocker were its more powerful hypotensive effect, the quicker onset of its action, less metabolic disturbance, decreased frequency of complaints and patient's preference. On thiazides body weight and the frequency of swollen ankles decreased. Plasma renin concentration was not found to have a strong predicting power for the hypotensive effect of atenolol or bendrofluazide but low renin patients showed a more pronounced blood pressure decrease on bendrofluazide and high renin patients, especially essential hypertensives, on atenolol. While these points can be a guide to therapy today, the preference of one drug over the other must eventually be based on their relative efficacy in decreasing morbidity and mortality from the hypertensive disease.\",\n",
       "  'journal': 'Acta cardiologica',\n",
       "  'authors': 'R Fagard;A Amery;JF De Plaen;P Lijnen;A Missotten',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '14468',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D001262:Atenolol; D001539:Bendroflumethiazide; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension; D006977:Hypertension, Renal; D008297:Male; D010349:Patient Compliance; D010919:Placebos; D011412:Propanolamines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011412:Propanolamines; D001262:Atenolol; D001539:Bendroflumethiazide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Cardiol',\n",
       "  'nlm_unique_id': '0370570',\n",
       "  'issn_linking': '0001-5385',\n",
       "  'country': 'England'},\n",
       " {'title': 'The general management of hypertension.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Australian and New Zealand journal of medicine',\n",
       "  'authors': '',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '14615',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000368:Aged; D000818:Animals; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003000:Clonidine; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension; D006974:Hypertension, Malignant; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D051381:Rats; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1445-5994.1976.tb03345.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aust N Z J Med',\n",
       "  'nlm_unique_id': '1264322',\n",
       "  'issn_linking': '0004-8291',\n",
       "  'country': 'Australia'}]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "empty[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Evaluation of a palliative care service: problems and pitfalls.',\n",
       "  'abstract': \"OBJECTIVE\\nTo evaluate a palliative care home support team based on an inpatient unit.\\n\\n\\nDESIGN\\nRandomised controlled trial with waiting list. Patients in the study group received the service immediately, those in the control group received it after one month. Main comparison point was at one month.\\n\\n\\nSETTING\\nA city of 300,000 people with a publicly funded home care service and about 200 general practitioners, most of whom provide home care.\\n\\n\\nMAIN OUTCOME MEASURES\\nPain and nausea levels were measured at entry to trial and at one month, as were quality of life for patients and care givers' health.\\n\\n\\nRESULTS\\nBecause of early deaths, problems with recruitment, and a low compliance rate for completion of questionnaires, the required sample size was not attained.\\n\\n\\nCONCLUSION\\nIn designing evaluations of palliative care services, investigators should be prepared to deal with the following issues: attrition due to early death, opposition to randomisation by patients and referral sources, ethical problems raised by randomisation of dying patients, the appropriate timing of comparison points, and difficulties of collecting data from sick or exhausted patients and care givers. Investigators may choose to evaluate a service from various perspectives using different methods: controlled trials, qualitative studies, surveys, and audits. Randomised trials may prove to be impracticable for evaluation of palliative care.\",\n",
       "  'journal': 'BMJ (Clinical research ed.)',\n",
       "  'authors': 'IR McWhinney;MJ Bass;A Donner',\n",
       "  'pubdate': '1994',\n",
       "  'pmid': '7532501',\n",
       "  'mesh_terms': 'D002170:Canada; D035061:Control Groups; D006302:Health Services Research; D006699:Home Care Services; D017051:Hospice Care; D006801:Humans; D009325:Nausea; D010146:Pain; D059408:Pain Management; D010166:Palliative Care; D010349:Patient Compliance; D018579:Patient Selection; D011788:Quality of Life; D035842:Research Subjects',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Death and Euthanasia; Empirical Approach; London (ON)',\n",
       "  'doi': '10.1136/bmj.309.6965.1340',\n",
       "  'references': '7419845;6143195;6374052;3966617;10311102;2860399;4042058;3511080;1483075;8096011;7911916',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Thames Valley Family Practice Research Unit, University of Western Ontario, London, Canada.',\n",
       "  'pmc': '',\n",
       "  'other_id': '46025',\n",
       "  'medline_ta': 'BMJ',\n",
       "  'nlm_unique_id': '8900488',\n",
       "  'issn_linking': '0959-8138',\n",
       "  'country': 'England'},\n",
       " {'title': 'Results and implications of the INCAP follow-up study.',\n",
       "  'abstract': 'This article is a critical synthesis of 12 papers included in this supplement. The set deals with the short- and long-term effects of improving nutrition in Guatemalan villages characterized by deficient diets, high rates of infection and pronounced growth retardation in the first 3 y of life. The data reviewed come from two studies carried out over two decades: the Institute of Nutrition of Central America and Panama (INCAP) longitudinal study (1966-1977) and its follow-up (1988-1989). The longitudinal study included a nutrition intervention that improved the energy and nutrient intakes of women and preschool children. Its effects included improved birthweights, reduced infant mortality rates and improved growth rates in children < 3 y of age. Growth rates from 3 to 7 y of age, similar to those of well-nourished children, were not affected by the intervention. The follow-up study was conducted when the subjects were 11-27 y old. Among the long-term effects found were greater stature and fat-free mass, particularly in females, improved work capacity in males and enhanced intellectual performance in both genders. The nutrition intervention did not, on the other hand, accelerate maturation during adolescence, as measured by skeletal age or age at menarche. It is concluded that improved nutrition in early childhood has important long-term effects in the adolescent and adult.',\n",
       "  'journal': 'The Journal of nutrition',\n",
       "  'authors': 'R Martorell',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7536833',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D015362:Child Nutrition Disorders; D002675:Child, Preschool; D002658:Developmental Disabilities; D005260:Female; D005500:Follow-Up Studies; D005527:Food, Fortified; D006130:Growth Disorders; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011247:Pregnancy',\n",
       "  'publication_types': \"D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/jn/125.suppl_4.1127S',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Department of International Health, Rollins School of Public Health of Emory University, Atlanta, GA 30322, USA.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Nutr',\n",
       "  'nlm_unique_id': '0404243',\n",
       "  'issn_linking': '0022-3166',\n",
       "  'country': 'United States'},\n",
       " {'title': 'An overview of current pharmacotherapy in perennial rhinitis.',\n",
       "  'abstract': 'BACKGROUND\\nIndividuals with rhinitis experience significant morbidity due to their disease. Research and clinical care to reduce this suffering are important.\\n\\n\\nOBJECTIVE\\nTo review the pharmacological agents that have been developed for the treatment of perennial rhinitis.\\n\\n\\nMETHOD\\nLiterature review of human studies.\\n\\n\\nRESULTS\\nMedication classes include antihistamines, decongestants, anticholinergics, cromolyn sodium, and corticosteroids. These vary in regard to their pharmacology, efficacy, and adverse effects. Compliance and cost issues are also critical components of the therapeutic regimen.\\n\\n\\nCONCLUSION\\nCarefully chosen pharmacotherapy based on an understanding of the pathophysiology of the disease, knowledge of the potential of medications, and commitment to an ongoing patient/physician education and monitoring program can lead to improved well-being for individuals with perennial rhinitis.',\n",
       "  'journal': 'The Journal of allergy and clinical immunology',\n",
       "  'authors': 'EO Meltzer',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7538519',\n",
       "  'mesh_terms': 'D018680:Cholinergic Antagonists; D004205:Cromolyn Sodium; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006801:Humans; D014663:Nasal Decongestants; D010349:Patient Compliance; D012221:Rhinitis, Allergic, Perennial',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D018680:Cholinergic Antagonists; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D004205:Cromolyn Sodium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-6749(95)70213-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Allergy and Asthma Medical Group and Research Center, San Diego, CA 92123, USA.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Allergy Clin Immunol',\n",
       "  'nlm_unique_id': '1275002',\n",
       "  'issn_linking': '0091-6749',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.\",\n",
       "  'abstract': \"BACKGROUND\\nIn patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival. However, even after effective chemotherapy the risk of nodal relapse is not negligible, and not only in initial bulky site(s) of disease. For this reason, in an attempt to prevent relapses after combination chemotherapy alone, we performed a prospective study to evaluate the efficacy and toxic effects of 6 courses of hybrid MOPP/ABVD followed by radiotherapy (RT) in stages II A bulky, II B, III and also in stage IV with bulky disease of residual after chemotherapy.\\n\\n\\nPATIENTS AND METHODS\\nFrom January 1985 to August 1993, 133 patients with HD (128 newly diagnosed, stage II A bulky-IV, 5 in first relapse after RT) were treated according to the following program: 6 courses of the hybrid MOPP/ABVD regimen followed by RT (STNI + spleen in stages II A, II B, III without pelvic lymph node involvement, TNI + spleen in stage III with pelvic lymph node involvement, involved field in stage IV with bulky disease or residual after chemotherapy). The total dose of RT was 4000 cGy to the sites of bulky or residual disease and 2000 cGy to the other sites.\\n\\n\\nRESULTS\\nAfter hybrid MOPP/ABVD, 107 of 130 (82.3%) fully evaluable patients were classified as in CR or CR(U). After completion of RT, 108 patients were in CR and 3 were in PR, for an overall response rate of 85%. With a median follow-up duration of 45 months, the actuarial 5-year survival is 76% and the progression-free survival 68.6%. So far, only 14 patients have relapsed (6 within the irradiation field) and the 5-year relapse-free survival is 82.5%.\\n\\n\\nCONCLUSION\\nSix courses of hybrid MOPP/ABVD followed by RT in stages II A bulky, II B, III and in stage IV with bulky disease or residual after chemotherapy produced a high CR rate with low risk of relapse. However, a longer follow-up is necessary to evaluate the late effects of combined therapy.\",\n",
       "  'journal': 'Annals of oncology : official journal of the European Society for Medical Oncology',\n",
       "  'authors': 'L Salvagno;M Sorar;G Sotti;S Aversa;V Chiarion Sileni;R Mazzarotto;G Scarzello;A Bianco;GL Pappagallo;MV Fiorentino',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7540419',\n",
       "  'mesh_terms': 'D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001761:Bleomycin; D001855:Bone Marrow Diseases; D003131:Combined Modality Therapy; D003606:Dacarbazine; D004317:Doxorubicin; D005260:Female; D006689:Hodgkin Disease; D006801:Humans; D015182:Lymphatic Irradiation; D008297:Male; D008466:Mechlorethamine; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D016609:Neoplasms, Second Primary; D010349:Patient Compliance; D011241:Prednisone; D011344:Procarbazine; D011379:Prognosis; D011446:Prospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D014747:Vinblastine; D014750:Vincristine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.annonc.a059113',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Division of Medical Oncology, Centro Oncologico Regionale, Padova, Italy.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Oncol',\n",
       "  'nlm_unique_id': '9007735',\n",
       "  'issn_linking': '0923-7534',\n",
       "  'country': 'England'},\n",
       " {'title': 'Patient education: patient willingness vs. nursing skill.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ostomy/wound management',\n",
       "  'authors': 'NA Faller;KG Lawrence',\n",
       "  'pubdate': '1994',\n",
       "  'pmid': '7546088',\n",
       "  'mesh_terms': 'D002983:Clinical Competence; D006801:Humans; D016294:Models, Nursing; D009730:Nursing Assessment; D010349:Patient Compliance; D010353:Patient Education as Topic',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ostomy Wound Manage',\n",
       "  'nlm_unique_id': '8912029',\n",
       "  'issn_linking': '0889-5899',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Preventive therapy for tuberculosis in HIV infection: the promise and the reality.',\n",
       "  'abstract': '',\n",
       "  'journal': 'AIDS (London, England)',\n",
       "  'authors': \"RJ O'Brien;JH Perrins\",\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7546409',\n",
       "  'mesh_terms': 'D017088:AIDS-Related Opportunistic Infections; D000328:Adult; D000995:Antitubercular Agents; D056486:Chemical and Drug Induced Liver Injury; D003362:Cost-Benefit Analysis; D006801:Humans; D007538:Isoniazid; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant; D014397:Tuberculosis, Pulmonary',\n",
       "  'publication_types': 'D016421:Editorial; D016454:Review',\n",
       "  'chemical_list': 'D000995:Antitubercular Agents; D007538:Isoniazid',\n",
       "  'keywords': 'Delivery Of Health Care; Diseases; Drugs; Health; Health Services; Hiv Infections; Infections; Literature Review; Medicine; Preventive Medicine; Treatment; Tuberculosis; Viral Diseases',\n",
       "  'doi': '10.1097/00002030-199507000-00001',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '106282; 00242045',\n",
       "  'medline_ta': 'AIDS',\n",
       "  'nlm_unique_id': '8710219',\n",
       "  'issn_linking': '0269-9370',\n",
       "  'country': 'England'},\n",
       " {'title': \"Does encouraging good compliance improve patients' clinical condition in heart failure?\",\n",
       "  'abstract': 'The aim of this study was to determine whether improved compliance by intensive medication counselling, given by a pharmacist, to elderly patients with chronic stable heart failure can influence both objective and subjective measures of heart failure. Elderly patients were randomly allocated to receive a 3-month counselling programme, or no counselling. Measures recorded at the beginning and end of the study included; submaximal 6-minute exercise tests, visual analogue scores of breathlessness, the Nottingham Health Profile, and clinical signs of heart failure. Compliance was measured by a tablet count and medication knowledge assessed by means of a questionnaire. There was no significant difference between the groups in their initial level of compliance, medication knowledge or other assessments. Compliance improved for the counselled group by 32% (P < 0.001) but remained unchanged for controls. Medication knowledge improved for the counselled group only. The 6-minute exercise test improved by 20 metres from a baseline of 137 m for the counselled group (P < 0.005) but worsened by 22 m for the control group (P < 0.01). Distance to breathlessness improved for the counselled patients and worsened for controls. In contrast bodyweight, jugular venous pressure and Nottingham Health Profile scores did not change significantly for either group. Peripheral and pulmonary oedema scores improved for the counselled group (P < 0.01) but remained unchanged for controls. A small improvement was seen in the visual analogue scores (P < 0.05) for the counselled group only. Improved compliance due to intensive medication counselling had a small but measurable beneficial effect on objective measures of heart failure.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'The British journal of clinical practice',\n",
       "  'authors': 'LI Goodyer;F Miskelly;P Milligan',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7547154',\n",
       "  'mesh_terms': 'D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006333:Heart Failure; D006801:Humans; D008297:Male; D010349:Patient Compliance; D010353:Patient Education as Topic; D011446:Prospective Studies; D016896:Treatment Outcome',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': \"Department of Pharmacy, King's College London.\",\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Clin Pract',\n",
       "  'nlm_unique_id': '0372546',\n",
       "  'issn_linking': '0007-0947',\n",
       "  'country': 'England'},\n",
       " {'title': 'Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?',\n",
       "  'abstract': 'As part of a programme assessing the pharmacokinetics of oral thiopurines given for lymphoblastic leukaemia, we assayed intracellular metabolites of mercaptopurine in children from all over the United Kingdom who were given a standard dose of the drug. The metabolites we measured, thioguanine nucleotides and methylmercaptopurines, are products of two competing metabolic pathways and would be expected to show an inverse correlation. A total of 327 children from 17 centres in the UK were studied. All were on the same therapeutic schedule of mercaptopurine. All had been on an unattenuated full protocol-directed dose (at least 75 mg m-2) for a minimum of 7 days before assay. There was a very wide variation in the concentration of the two metabolites measured; the thioguanine nucleotides ranged from 0 to 1255 pmol per 8 x 10(8) red cells (median 289, lower quartile 210, upper quartile 377) and the methylmercaptopurine metabolites ranged from 0 to 46.3 nmol per 8 x 10(8) red cells (median 5.18, lower quartile 2.31, upper quartile 11.59). The anticipated negative correlation was not apparent, but the ratio between the two was not randomly distributed. No child had both metabolite concentrations in the upper quartiles, but in 32 (10%) children the concentration of both metabolites was in the lower quartile. Of the 32, only one metabolite was detected in four and none at all in six. The most likely explanation for these findings is that a minority of children with lymphoblastic leukaemia fail to take oral mercaptopurine either totally or intermittently. The extent of the problem is unknown, but we suspect it may be clinically important in at least 10% of patients.',\n",
       "  'journal': 'British journal of cancer',\n",
       "  'authors': 'L Lennard;J Welch;JS Lilleyman',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7547211',\n",
       "  'mesh_terms': 'D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D015122:Mercaptopurine; D008780:Methyltransferases; D010349:Patient Compliance; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1038/bjc.1995.450',\n",
       "  'references': '8499854;8413409;8257179;8299312;7909868;7823668;7758006;761160;7208140;3731045;1973780;1448843;1484095',\n",
       "  'delete': False,\n",
       "  'affiliations': 'University of Sheffield Department of Medicine and Pharmacology, Royal Hallamshire Hospital, UK.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Cancer',\n",
       "  'nlm_unique_id': '0370635',\n",
       "  'issn_linking': '0007-0920',\n",
       "  'country': 'England'},\n",
       " {'title': 'Treatment of pulmonary tuberculosis in children: new trends.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Pediatric pulmonology. Supplement',\n",
       "  'authors': 'RL Seplveda',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7547331',\n",
       "  'mesh_terms': 'D000995:Antitubercular Agents; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009017:Morbidity; D010349:Patient Compliance; D015996:Survival Rate; D014397:Tuberculosis, Pulmonary',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000995:Antitubercular Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ppul.1950191115',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'National Institute of Respiratory Diseases and Thoracic Surgery, Faculty of Medicine, University of Chile, Santiago.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pediatr Pulmonol Suppl',\n",
       "  'nlm_unique_id': '9014095',\n",
       "  'issn_linking': '1054-187X',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Update in allergy testing in childhood asthma: how do you know whether you are successfully controlling the patient's inflammation?\",\n",
       "  'abstract': 'The levels of serum eosinophil cationic protein (ECP) in asthmatic patients have been shown to be increased in acute and undertreated asthma as a result of inflammation. ECP is released during in vitro clotting of peripheral blood. The exposure of the atopic individual to an offending allergen stimulates the activation of the blood eosinophils and their release of ECP into serum. Serum ECP levels reflect avoidance of the allergen, and successful treatment of asthma inflammation with corticosteroids cause a reduction of the inflammation in the lung. When individual patients with asthma are followed, the level of serum ECP can be used (1) as an early indicator of the degree of inflammation, (2) for monitoring the efficacy of corticosteroid therapy, and (3) for possible noncompliance with treatment.',\n",
       "  'journal': 'Pediatric pulmonology. Supplement',\n",
       "  'authors': 'S Ahlstedt;CG Peterson;I Enander',\n",
       "  'pubdate': '1995',\n",
       "  'pmid': '7547335',\n",
       "  'mesh_terms': 'D000893:Anti-Inflammatory Agents; D001249:Asthma; D001798:Blood Proteins; D001985:Bronchial Provocation Tests; D002648:Child; D002675:Child, Preschool; D047091:Eosinophil Granule Proteins; D005938:Glucocorticoids; D006801:Humans; D006967:Hypersensitivity; D018836:Inflammation Mediators; D010349:Patient Compliance; D012260:Ribonucleases; D012680:Sensitivity and Specificity; D013256:Steroids',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D005938:Glucocorticoids; D018836:Inflammation Mediators; D013256:Steroids; D012260:Ribonucleases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ppul.1950191118',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Pharmacia Diagnostics AB, Uppsala, Sweden.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pediatr Pulmonol Suppl',\n",
       "  'nlm_unique_id': '9014095',\n",
       "  'issn_linking': '1054-187X',\n",
       "  'country': 'United States'}]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "empty1[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'E-FALCONS. A mnemonic for monitoring the prescribing of atypical antipsychotics.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Geriatrics',\n",
       "  'authors': 'T Gill;HR Khouzam;DT Tan',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15332416',\n",
       "  'mesh_terms': 'D000058:Accidental Falls; D000368:Aged; D014150:Antipsychotic Agents; D001480:Basal Ganglia Diseases; D001772:Blood Cell Count; D001786:Blood Glucose; D016903:Drug Monitoring; D011307:Drug Prescriptions; D020820:Dyskinesias; D004562:Electrocardiography; D005215:Fasting; D006331:Heart Diseases; D006801:Humans; D006937:Hypercholesterolemia; D008111:Liver Function Tests; D009459:Neuroleptic Malignant Syndrome; D009765:Obesity; D010349:Patient Compliance; D011618:Psychotic Disorders; D012307:Risk Factors; D012640:Seizures',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D001786:Blood Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Inpatient Psychiatry Unit, Veterans Affairs Central California Health Care System, Fresno, USA.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Geriatrics',\n",
       "  'nlm_unique_id': '2985102R',\n",
       "  'issn_linking': '0016-867X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Patterns of antihypertensive medication use in hemodialysis patients.',\n",
       "  'abstract': 'PURPOSE\\nPatterns of antihypertensive drug use in patients undergoing long-term hemodialysis therapy were studied.\\n\\n\\nMETHODS\\nPatients attending seven outpatient hemodialysis units in Ohio were eligible for the study if they had been receiving the treatment for at least three months. Demographic and clinical data were obtained from patient interviews and computerized databases, and blood pressure (BP) measurements were obtained before dialysis. Labeled names and dosages of antihypertensive drugs were recorded from containers the patients brought with them. Patients were asked to describe their adherence to the medications, their ability to afford the drugs, and their knowledge and beliefs about hypertension. Physical impairments in taking medication were also evaluated.\\n\\n\\nRESULTS\\nThe frequency of hypertension was 89% in the 270 participants. Antihypertensive drugs were prescribed for 76% of the patients; 25% required three or more drugs. Hypertensive patients who were not receiving antihypertensive drugs (14%) had significantly higher BP than patients who were. Calcium-channel blockers were prescribed for 60% of patients, angiotensin-converting-enzyme inhibitors for 33%, and beta-blockers for 34%. Eighty-three percent said the cost of drugs was never a problem, and 23% said they sometimes forgot to take their medication. Almost all patients said they would not stop taking antihypertensive drugs if they were feeling better and agreed that monitoring BP was important. Twenty-two percent could not read the warning on a standard tablet container, and 12% could not remove one tablet from the container.\\n\\n\\nCONCLUSION\\nMultidrug antihypertensive therapy was common among hemodialysis patients and was associated with significantly lower BP; calcium-channel blockers were the most frequently prescribed agents. Most patients said they could afford drugs and reported good adherence to antihypertensive drug therapy.',\n",
       "  'journal': 'American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists',\n",
       "  'authors': 'M Rahman;V Griffin',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15332695',\n",
       "  'mesh_terms': 'D000959:Antihypertensive Agents; D001294:Attitude to Health; D001794:Blood Pressure; D005260:Female; D006801:Humans; D006973:Hypertension; D007676:Kidney Failure, Chronic; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D006435:Renal Dialysis',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000959:Antihypertensive Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/ajhp/61.14.1473',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Case Western Reserve University, University Hospitals of Cleveland and Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA. mahboob.rahman@uhhs.com',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Health Syst Pharm',\n",
       "  'nlm_unique_id': '9503023',\n",
       "  'issn_linking': '1079-2082',\n",
       "  'country': 'England'},\n",
       " {'title': 'Low rates of diabetic patients reaching good control targets.',\n",
       "  'abstract': 'A cross-sectional study was conducted of 404 diabetic patients attending King Abdulaziz University Hospital medical clinic from June 1998 to January 2000 in order to determine their rates of reaching target levels for blood glucose, blood pressure, serum lipids and body mass index. Greatest difficulty was found in reaching target levels for low-density lipoprotein and glycated haemoglobin. Target levels for blood pressure were harder to achieve for Saudis than non-Saudis. Significantly fewer females reached target levels for blood glucose, body mass index, low-density lipoprotein or all targets than males (both Saudi and non-Saudi). Efforts are needed to improve compliance to diet and drug regimens and to identify and treat risk factors in each patient.',\n",
       "  'journal': 'Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit',\n",
       "  'authors': 'DH Akbar',\n",
       "  'pubdate': '2001',\n",
       "  'pmid': '15332765',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose; D001794:Blood Pressure; D015992:Body Mass Index; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus; D005260:Female; D006442:Glycated Hemoglobin A; D006785:Hospitals, University; D006801:Humans; D008055:Lipids; D008077:Lipoproteins, LDL; D008297:Male; D008875:Middle Aged; D020380:Needs Assessment; D010044:Outpatient Clinics, Hospital; D010349:Patient Compliance; D012111:Residence Characteristics; D012307:Risk Factors; D012529:Saudi Arabia; D012737:Sex Factors; D013997:Time Factors',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D006442:Glycated Hemoglobin A; D008055:Lipids; D008077:Lipoproteins, LDL',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'King Abdulaziz University Hospital, Jeddah, Saudi Arabia.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'East Mediterr Health J',\n",
       "  'nlm_unique_id': '9608387',\n",
       "  'issn_linking': '1020-3397',\n",
       "  'country': 'Egypt'},\n",
       " {'title': 'Impact of educational mailing on the blood pressure of primary care patients with mild hypertension.',\n",
       "  'abstract': \"OBJECTIVE\\nTo assess the effectiveness of mailed hypertension educational materials.\\n\\n\\nDESIGN\\nProspective, randomized, controlled single-blind trial.\\n\\n\\nSETTING\\nPrimary care practice-based research network in which 9 clinics located in Portland, Oregon participated.\\n\\n\\nPARTICIPANTS\\nPatients with mildly uncontrolled hypertension as defined as a last blood pressure of 140 to 159/90 to 99 mmHg from query of an electronic medical record database.\\n\\n\\nINTERVENTIONS\\nPatients randomized to intervention were mailed 2 educational packets approximately 3 months apart. The first mailer included a letter from each patient's primary care provider. The mailer included a booklet providing an overview of hypertension and lifestyle modification and a refrigerator magnet noting target blood pressure. The second mailing also included a letter from the patient's primary care provider, a second educational booklet focused on medication compliance and home blood pressure monitoring, and a blood pressure logbook. The control group consisted of similar patients receiving usual care for hypertension.\\n\\n\\nMEASUREMENTS AND MAIN RESULTS\\nPatients from each group were randomly selected for invitation to participate in a study visit to measure blood pressure and complete a survey (intervention n= 162; control n= 150). No significant difference was found in mean blood pressure between intervention and control patients (135/77 mmHg vs 137/77 mmHg; P=.229). Patients in the intervention arm scored higher on a hypertension knowledge quiz (7.48 +/- 1.6 vs 7.06 +/- 1.6; P=.019), and reported higher satisfaction with several aspects of their care. No significant difference was seen in the prevalence of home blood pressure monitoring ownership or use.\\n\\n\\nCONCLUSIONS\\nIn patients with mildly uncontrolled hypertension, educational mailers did not yield a significant decrease in blood pressure. However, significant improvement in patient knowledge, frequency of home monitoring, and satisfaction with care were demonstrated.\",\n",
       "  'journal': 'Journal of general internal medicine',\n",
       "  'authors': 'JS Hunt;J Siemienczuk;D Touchette;N Payne',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333056',\n",
       "  'mesh_terms': 'D000368:Aged; D001794:Blood Pressure; D005260:Female; D006801:Humans; D006973:Hypertension; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D010817:Physician-Patient Relations; D011320:Primary Health Care',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016448:Multicenter Study; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1525-1497.2004.40046.x',\n",
       "  'references': '12415147;12671325;12851274;14656957;6786497;9148648;3945130;3503941;3228529;7875754;7578537;6193273',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Department of Primary Care Research and Pharmacy, Providence Health System, Oregon State University College of Pharmacy, USA. Jacquelyn.Hunt@providence.org',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Gen Intern Med',\n",
       "  'nlm_unique_id': '8605834',\n",
       "  'issn_linking': '0884-8734',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Monitoring visual status: why patients do or do not comply with practice guidelines.',\n",
       "  'abstract': 'OBJECTIVE\\nTo determine factors affecting compliance with guidelines for annual eye examinations for persons diagnosed with diabetes mellitus (DM) or age-related macular degeneration (ARMD).\\n\\n\\nDATA SOURCES/STUDY SETTING\\nNationally representative, longitudinal sample of individuals 65+ drawn from the National Long-Term Care Survey (NLTCS) with linked Medicare claims records from 1991 to 1999.\\n\\n\\nSTUDY DESIGN\\nMedicare beneficiaries were followed from 1991 to 1999, unless mortality intervened. All claims data were analyzed for presence of ICD-9 codes indicating diagnosis of DM or ARMD and the performance of eye exams. The dependent variable was a binary indicator for whether a person had an eye exam or not during a 15-month period. Independent variables for demographics, living conditions, supplemental insurance, income, and other factors affecting the marginal cost and benefit of an eye exam were assessed to determine reasons for noncompliance.\\n\\n\\nDATA COLLECTION/EXTRACTION METHODS\\nPanel data were created from claims files, 1991-1999, merged with data from the NLTCS.\\n\\n\\nPRINCIPAL FINDINGS\\nThe probability of having an exam reflected perceived benefits, which vary by patient characteristics (e.g., education, no dementia), and factors associated with the ease of visit. African Americans were much less likely to be examined than were whites.\\n\\n\\nCONCLUSIONS\\nHaving an exam reflects multiple factors. However, much of the variation in the probability of an exam remained unexplained as were reasons for the racial differences in use.',\n",
       "  'journal': 'Health services research',\n",
       "  'authors': 'FA Sloan;DS Brown;ES Carlisle;GA Picone;PP Lee',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333116',\n",
       "  'mesh_terms': 'D000368:Aged; D015897:Comorbidity; D003920:Diabetes Mellitus; D003930:Diabetic Retinopathy; D005128:Eye Diseases; D005260:Female; D005901:Glaucoma; D006801:Humans; D016015:Logistic Models; D008137:Longitudinal Studies; D008268:Macular Degeneration; D008297:Male; D006278:Medicare; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D012959:Socioeconomic Factors; D014481:United States; D014787:Vision Tests',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1475-6773.2004.00297.x',\n",
       "  'references': '9003167;9108834;9243653;9254871;10555610;10624032;10676791;10843311;10970252;11006067;11146840;11444579;11794915;12062916;12401533;14522771;2769192;1985609;1919495;1575066;1458516;10172666;9416028;9718220;9718540',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Department of Economics, Box 90097, Duke University, Durham, North Carolina, 27708, USA.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Health Serv Res',\n",
       "  'nlm_unique_id': '0053006',\n",
       "  'issn_linking': '0017-9124',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Point-of-care test to monitor adherence to anti-tuberculous treatment.',\n",
       "  'abstract': \"BACKGROUND\\nIn the fight against the global tuberculosis epidemic, it is essential to ensure that patients adhere to the treatment prescribed. As the treatment is given for a minimum of 6 months it is common for patients not to take their drugs regularly. Strategies are therefore needed to assess adherence to treatment. One established method is to examine the patient's urine for the presence of drug metabolites. A rapid point-of-care test would overcome some of the drawbacks associated with currently available methods.\\n\\n\\nMETHOD\\nA rapid, safe point-of-care test for isoniazid metabolites (IsoScreen, Surescreen Diagnostics Limited, Derby, UK) has been developed and used to help assess adherence to treatment in a busy clinic for tuberculosis patients in South London.\\n\\n\\nRESULTS\\nUrine samples were examined from 191 patients receiving isoniazid, usually in combination with rifampicin and other anti-tuberculous drugs. Isoscreen was positive in 93.2% of patients, suggesting that 6.8% might be poorly adhering to treatment. By contrast, examining the same urine samples for evidence of rifampicin ingestion gave positive results in only 43.5%, due to the fact that this test is only positive for a few hours after drug ingestion.\\n\\n\\nCONCLUSION\\nIsoScreen has been shown to provide a rapid and safe point-of-care test, which contributes to the detection of non-adherence in patients with tuberculosis.\",\n",
       "  'journal': 'Annals of clinical biochemistry',\n",
       "  'authors': 'R Whitfield;GF Cope',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333195',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007538:Isoniazid; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010349:Patient Compliance; D019095:Point-of-Care Systems',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000995:Antitubercular Agents; D007538:Isoniazid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1258/0004563041731637',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Chest Clinic, Mayday University Hospital, London Road, Thornton Heath, Surrey, CR7 7YE, UK. ruthwhitfield@btinternet.com',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Clin Biochem',\n",
       "  'nlm_unique_id': '0324055',\n",
       "  'issn_linking': '0004-5632',\n",
       "  'country': 'England'},\n",
       " {'title': 'A systematic review of adherence with medications for diabetes: response to Cramer.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Diabetes care',\n",
       "  'authors': 'J Wens;E Vermeire;P Van Royen;H Hearnshaw',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333510',\n",
       "  'mesh_terms': 'D003920:Diabetes Mellitus; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D007004:Hypoglycemic Agents; D010349:Patient Compliance; D015203:Reproducibility of Results',\n",
       "  'publication_types': 'D016420:Comment; D016422:Letter',\n",
       "  'chemical_list': 'D007004:Hypoglycemic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2337/diacare.27.9.2284',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Diabetes Care',\n",
       "  'nlm_unique_id': '7805975',\n",
       "  'issn_linking': '0149-5992',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial.\",\n",
       "  'abstract': 'BACKGROUND\\nEmergency contraception (EC) can prevent pregnancy but is under-used. Advanced provision increases use but the effect on contraceptive behaviour varies.\\n\\n\\nMETHODS\\nWomen aged 18-45 years, using less effective contraceptives, were randomized to either advanced provision of three courses of EC (intervention) or to obtaining each course from clinic (control). EC use and contraceptive behaviour were monitored for 1 year.\\n\\n\\nRESULTS\\nIn all, 1030 women were recruited in 6 months. The mean+/-SD number of courses of EC used in intervention versus control group was 0.56+/-1.2 versus 0.20+/-0.6 (P<0.001). In the intervention group, 47% women aged <26 years used at least one course of EC compared with 23% of older women (P<0.001). The majority of women used condoms before (intervention 89%, control 91%) and during the study (89% for both groups). Consistency of contraceptive use was higher during the study (65 versus 60% of women in both groups) (P<0.001). There were 17 unplanned pregnancies, eight in the intervention group, six of whom did not use EC in the conception cycle.\\n\\n\\nCONCLUSIONS\\nAdvanced provision increases EC use especially among young women in Hong Kong. Contraceptive choice and consistency of use remains the same even among young women.',\n",
       "  'journal': 'Human reproduction (Oxford, England)',\n",
       "  'authors': 'SS Lo;SY Fan;PC Ho;AF Glasier',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333602',\n",
       "  'mesh_terms': 'D000328:Adult; D003268:Contraception Behavior; D044363:Contraception, Postcoital; D003281:Contraceptives, Postcoital; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010349:Patient Compliance; D011247:Pregnancy; D018873:Pregnancy Rate; D045808:Refusal to Participate',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003281:Contraceptives, Postcoital',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/humrep/deh425',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'The Family Planning Association of Hong Kong, 9/F 130 Hennessy Road, Hong Kong SAR. stlo@famplan.org.hk',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hum Reprod',\n",
       "  'nlm_unique_id': '8701199',\n",
       "  'issn_linking': '0268-1161',\n",
       "  'country': 'England'},\n",
       " {'title': 'Blood pressure response to dietary modifications in free-living individuals.',\n",
       "  'abstract': 'A diet rich in fruits, vegetables, and low-fat dairy foods has been shown to lower blood pressure (BP) when all foods are provided. We compared the effect on BP (measured at home) of 2 different self-selected diets: a low-sodium, high-potassium diet, rich in fruit and vegetables (LNAHK) and a high-calcium diet rich in low-fat dairy foods (HC) with a moderate-sodium, high-potassium, high-calcium DASH-type diet, high in fruits, vegetables and low-fat dairy foods (OD). Subjects were randomly allocated to 2 test diets for 4 wk, the OD and either LNAHK or HC diet, each preceded by a 2 wk control diet (CD). The changes in BP between the preceding CD period and the test diet period (LNAHK or HC) were compared with the change between the CD and the OD periods. Of the 56 men and 38 women that completed the OD period, 43 completed the LNAHK diet period and 48 the HC diet period. The mean age was 55.6 +/- 9.9 (+/-SD) years. There was a fall in systolic pressure between and the CD and OD [-1.8 +/- 0.5 mm Hg (P < 0.001)]. Compared with OD, systolic and diastolic BPs fell during the LNAHK diet period [-3.5 +/- 1.0 (P < 0.001) and -1.9 +/- 0.7 (P < 0.05) mmHg, respectively] and increased during the HC diet period [+3.1 +/- 0.9 (P < 0.01) and +0.8 +/- 0.6 (P = 0.15) mm Hg, respectively]. A self-selected low-sodium, high-potassium diet resulted in a greater fall in BP than a multifaceted OD, confirming the beneficial effect of dietary intervention on BP in a community setting.',\n",
       "  'journal': 'The Journal of nutrition',\n",
       "  'authors': 'CA Nowson;A Worsley;C Margerison;MK Jorna;AG Frame;SJ Torres;SJ Godfrey',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15333723',\n",
       "  'mesh_terms': 'D000368:Aged; D001794:Blood Pressure; D001835:Body Weight; D002136:Calcium, Dietary; D018592:Cross-Over Studies; D004039:Diet, Sodium-Restricted; D004305:Dose-Response Relationship, Drug; D002149:Energy Intake; D005247:Feeding Behavior; D005260:Female; D006801:Humans; D008055:Lipids; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D017419:Potassium, Dietary',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002136:Calcium, Dietary; D008055:Lipids; D017419:Potassium, Dietary',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/jn/134.9.2322',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Centre for Physical Activity and Nutrition, School of Health Sciences, Deakin University, Burwood, Australia. nowson@deakin.edu.au',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Nutr',\n",
       "  'nlm_unique_id': '0404243',\n",
       "  'issn_linking': '0022-3166',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis.',\n",
       "  'abstract': 'OBJECTIVE\\nTo describe the frequency of complementary and alternative medicine (CAM) use in patients with juvenile idiopathic arthritis (JIA) and to explore whether CAM was associated with patient-specific characteristics, parent-specific characteristics, and medical management factors.\\n\\n\\nMETHODS\\nParents of children with JIA completed questionnaires that addressed the use of CAM, adherence and perceived problems, parental distress, and coping with childhood illness. Clinical variables were abstracted from the patients\\' medical files.\\n\\n\\nRESULTS\\nOne hundred-eighteen children with JIA, mean +/- SD age of 10.4 +/- 3.9 years and mean +/- SD disease duration of 4.5 +/- 3.5 years, participated in the study. Ever use of CAM was 33.9% and was higher in patients whose parents used CAM (odds ratio [OR] 5.1, 95% confidence interval [95% CI] 1.4-19.5) and among those who considered themselves as \"Canadian\" as opposed to belonging to a specific ethnic group (OR 10. 7, 95% CI 1.2-99.8). Adherence to conventional treatment was high for both users and nonusers of CAM.\\n\\n\\nCONCLUSION\\nUse of CAM is common among patients with JIA. CAM use is not related to any decrease in adherence to conventional medical treatment.',\n",
       "  'journal': 'Arthritis and rheumatism',\n",
       "  'authors': 'DE Feldman;C Duffy;M De Civita;P Malleson;L Philibert;M Gibbon;O Ortiz-Alvarez;PL Dobkin',\n",
       "  'pubdate': '2004',\n",
       "  'pmid': '15334423',\n",
       "  'mesh_terms': 'D000223:Adaptation, Psychological; D000293:Adolescent; D001171:Arthritis, Juvenile; D001290:Attitude; D002648:Child; D002675:Child, Preschool; D000529:Complementary Therapies; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010349:Patient Compliance; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/art.20536',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Universit de Montral, Montreal, Quebec, Canada. debbie.feldman@umontreal.ca',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arthritis Rheum',\n",
       "  'nlm_unique_id': '0370605',\n",
       "  'issn_linking': '0004-3591',\n",
       "  'country': 'United States'}]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "empty2[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Management of urinary tract infections: what do doctors recommend and patients do? An observational study in German primary care.',\n",
       "  'abstract': \"BACKGROUND\\nUncomplicated urinary tract infections (UTIs) in women are usually managed in primary care with antibiotics. However, many women seem to prefer to handle UTI symptoms with nonsteroidal anti-inflammatory drugs (NSAIDs) and other remedies. The aim of this study was to compare UTI management as recommended by physicians with the patients' management at home.\\n\\n\\nMETHODS\\nThis prospective cohort study in German primary care is based on clinical data from local practices and patient questionnaires. Participating women completed a baseline data sheet in the practice; their urine sample was tested by a dipstick in the practice and cultured by a laboratory. The women reported treatment and symptom-related impairment on an eight-item symptom questionnaire daily for 7\\u2009days. Using growth curve models, we analysed the influence of time on the total severity score to examine how symptoms changed across days. We then examined whether symptom severity and symptom course differed between patients who took antibiotics or NSAIDs.\\n\\n\\nRESULTS\\nA total of 120 women (mean age of 43.3\\u2009\\u200916.6\\u2009years) were enrolled. The urine dipstick was positive for leucocytes in 92%, erythrocytes in 87%, and nitrites in 23%. Physicians prescribed antibiotics for 102 (87%) women and recommended NSAIDs in 14 cases. According to the women's reports, only 60% (72/120) took antibiotics, while the remainder took NSAIDs and other remedies. Symptoms declined from day 0 to day 6, irrespective of whether women decided to take an antibiotic, NSAIDs, none or both, as confirmed by a significant curvilinear time effect (B\\xa0=\\u20090.06, SE\\xa0=\\u20090.005, p\\xa0<\\u2009.001). The symptom course, however, was moderated by taking antibiotics so that the change in symptom severity was somewhat more pronounced in women taking antibiotics (B\\xa0=\\u20090.06) than in the remainder (B\\xa0=\\u20090.04).\\n\\n\\nCONCLUSION\\nA substantial proportion of women did not follow their physicians' treatment recommendations, and many used NSAIDs. All women had a good chance of recovery irrespective of whether they decided to take antibiotics. A sensitive listening to patient preferences in the consultation may encourage physicians to recommend and prescribe symptomatic treatment with NSAID more often than antibiotic medicines.\",\n",
       "  'journal': 'BMC infectious diseases',\n",
       "  'authors': 'I Ggyor;S Strube-Plaschke;K Rentzsch;W Himmel',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33167875',\n",
       "  'mesh_terms': 'D000328:Adult; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli; D004927:Escherichia coli Infections; D005260:Female; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010820:Physicians; D011320:Primary Health Care; D011446:Prospective Studies; D012017:Referral and Consultation; D011795:Surveys and Questionnaires; D014552:Urinary Tract Infections',\n",
       "  'publication_types': 'D016428:Journal Article; D064888:Observational Study',\n",
       "  'chemical_list': 'D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal',\n",
       "  'keywords': 'Anti bacterial agents; Non-steroidal anti-inflammatory agents; Primary health care; Prospective studies; Quality of life; Surveys and questionnaires; Symptom assessment; Urinary tract infection',\n",
       "  'doi': '10.1186/s12879-020-05377-w',\n",
       "  'references': '29113968;29970072;26412847;28585332;28684025;26698878;20139217;20504298;21671766;26754175;20139214;29158245;23171154;30135009;23721260;24484571;28424057;29763434;30689491;27820528;30168406;28486532;15640290;21127022;17449887;12509362;28894499',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Department of General Practice, Universittsklinikum Wrzburg, Josef-Schneider-Str. 2/D7, 97080, Wrzburg, Germany. Gagyor_I@ukw.de.;Department of General Practice, Gttingen University Medical Center, Humboldtallee 38, 37073, Gttingen, Germany.;Department of Psychology, Psychologische Hochschule Berlin, Am Kllnischen Park 2, 10179, Berlin, Germany.;Department of General Practice, Gttingen University Medical Center, Humboldtallee 38, 37073, Gttingen, Germany.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'BMC Infect Dis',\n",
       "  'nlm_unique_id': '100968551',\n",
       "  'issn_linking': '1471-2334',\n",
       "  'country': 'England'},\n",
       " {'title': 'Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020.',\n",
       "  'abstract': 'BACKGROUND\\nThe coronavirus disease 2019 (COVID-19) pandemic caused disruptions to healthcare systems and endangered the control and prevention of tuberculosis (TB). We investigated the nationwide effects of COVID-19 on the national Public-Private Mix (PPM) TB control project in Korea, using monitoring indicators from the Korean PPM monitoring database.\\n\\n\\nMETHODS\\nThe Korean PPM monitoring database includes data from patients registered at PPM hospitals throughout the country. Data of six monitoring indicators for active TB cases updated between July 2019 and June 2020 were collected. The data of each cohort throughout the country and in Daegu-Gyeongbuk, Seoul Metropolitan Area, and Jeonnam-Jeonbuk were collated to provide nationwide data. The data were compared using the  test for trend to evaluate quarterly trends of each monitoring indicator at the national level and in the prespecified regions.\\n\\n\\nRESULTS\\nTest coverages of sputum smear (P = 0.622) and culture (P = 0.815), drug susceptibility test (P = 0.750), and adherence rate to initial standard treatment (P = 0.901) at the national level were not significantly different during the study period. The rate of loss to follow-up among TB cases at the national level was not significantly different (P = 0.088); however, the treatment success rate among the smear-positive drug-susceptible pulmonary TB cohort at the national level significantly decreased, from 90.6% to 84.1% (P < 0.001). Treatment success rate in the Seoul metropolitan area also significantly decreased during the study period, from 89.4% to 84.5% (P = 0.006).\\n\\n\\nCONCLUSION\\nOur study showed that initial TB management during the COVID-19 pandemic was properly administered under the PPM project in Korea. However, our study cannot confirm or conclude a decreased treatment success rate after the COVID-19 pandemic due to limited data.',\n",
       "  'journal': 'Journal of Korean medical science',\n",
       "  'authors': 'J Min;HW Kim;HK Koo;Y Ko;JY Oh;J Kim;J Yang;Y Kwon;YJ Park;JY Kang;SS Lee;JS Park;JS Kim',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33169559',\n",
       "  'mesh_terms': 'D000995:Antitubercular Agents; D000073640:Betacoronavirus; D000086382:COVID-19; D018352:Coronavirus Infections; D016208:Databases, Factual; D003695:Delivery of Health Care; D004352:Drug Resistance, Microbial; D006801:Humans; D058873:Pandemics; D010349:Patient Compliance; D011024:Pneumonia, Viral; D056910:Republic of Korea; D000086402:SARS-CoV-2; D013183:Sputum; D014376:Tuberculosis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000995:Antitubercular Agents',\n",
       "  'keywords': 'Coronavirus; Public-private Sector Partnerships; Quality Indicators; SARS Virus; Treatment Outcome',\n",
       "  'doi': '10.3346/jkms.2020.35.e388',\n",
       "  'references': '32513783;32722014;32610836;26886846;31484578;32753044;27812491;32672531;32513784;32604016;32347772',\n",
       "  'delete': False,\n",
       "  'affiliations': \"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.;Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.;Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.;Division of Tuberculosis Prevention and Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Osong, Korea.;Division of Tuberculosis Prevention and Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Osong, Korea.;Division of Tuberculosis Prevention and Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Osong, Korea.;Director for Epidemiological Investigation Analysis, Director General for Public Health Emergency Preparedness, Korea Disease Control and Prevention Agency, Cheongju, Korea.;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.;Division of Pulmonary Medicine, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.;Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. kimjusang@catholic.ac.kr.\",\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Korean Med Sci',\n",
       "  'nlm_unique_id': '8703518',\n",
       "  'issn_linking': '1011-8934',\n",
       "  'country': 'Korea (South)'},\n",
       " {'title': 'Intelligent rehabilitation assistant system to promote the early functional recovery of the elderly patients with femoral neck fracture after hemiarthroplasty (HA): A protocol for a randomized controlled trial.',\n",
       "  'abstract': 'BACKGROUND\\nFemoral neck fracture is a common type of hip fracture, which has a high morbidity and mortality. Surgical treatment is the first choice. However, the functional rehabilitation after operation has not been paid enough attention. In addition, the quality of exercise is difficult to quantify, and the rehabilitation is lack of standards. Therefore, the intelligent rehabilitation assistant system which could record exercise details, might be used to evaluate the quality and adherence to the prescribed exercise to this fragile group of patients has great relevance, so as to provide new ideas for postoperative rehabilitation of hip fracture.\\n\\n\\nMETHODS\\nThis is an opening, prospective, double-dummy RCT. Fifty femoral neck fractures patients, older than 65 years and are about to hospitalize for HA, will be invited to study. The sample will be divided into monitoring group and control group randomly at a 1:1 ratio. The prescribed exercises need to be done continuously for 2 weeks. The monitoring group needs additional use intelligent rehabilitation assistant system. Each subject will receive a total of 4 follow-up visits at the designated time (2 weeks, 4 weeks, 12 weeks, and 24 weeks). The following factors will be talked as dependent variables:Each subject will receive a total of 4 follow-up visits at the designated time, and the findings will be analyzed statistically considering a 5% significance level (P\\u200a<\\u200a.05).\\n\\n\\nDISCUSSION\\nExercise under monitor may improve patients compliance and exercise quality, and accelerate the rehabilitation process. This protocol reported in accordance with the CONSORT 2010 checklist and SPIRIT 2013 Checklist.\\n\\n\\nTRIAL REGISTRATION\\nThe trial is registered at Chinese Clinical Trials Registry (ChiCTR2000033213, May 24, 2020).',\n",
       "  'journal': 'Medicine',\n",
       "  'authors': 'Z Li;H Lin;X Wang;M Huang;J Feng;J Feng;J Gao;J Wu;Z Jiang',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33181672',\n",
       "  'mesh_terms': 'D000368:Aged; D000369:Aged, 80 and over; D001185:Artificial Intelligence; D004311:Double-Blind Method; D005081:Exercise Therapy; D005260:Female; D005265:Femoral Neck Fractures; D062785:Hemiarthroplasty; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D020127:Recovery of Function; D016896:Treatment Outcome',\n",
       "  'publication_types': 'D000078325:Clinical Trial Protocol; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/MD.0000000000023078',\n",
       "  'references': '30285645;30419130;22842835;31977059;31503309;20929467;28187745;24549550;28137475;18760151;5425640;31547979;12061475;29589050;30517613;18056740;22198639;28488559;21944168;31128909;26975205;28805094;28484993;31781735;17162171;29851157;31115650;30471472;31409337',\n",
       "  'delete': False,\n",
       "  'affiliations': \"The First School of Clinical Medicine.;The First School of Clinical Medicine.;Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine.;The First School of Clinical Medicine.;The First School of Clinical Medicine.;The First School of Clinical Medicine.;The First School of Clinical Medicine.;The First School of Clinical Medicine.;The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.\",\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Medicine (Baltimore)',\n",
       "  'nlm_unique_id': '2985248R',\n",
       "  'issn_linking': '0025-7974',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Smartphone education improves embarrassment, bowel preparation, and satisfaction with care in patients receiving colonoscopy: A randomized controlled trail.',\n",
       "  'abstract': \"BACKGROUND\\nColonoscopy is considered a safe and effective tool for detecting colorectal cancer. Nevertheless, the proportion of patients are hesitating to receive colonoscopy. Smartphone education may decrease the barrier of colonoscopy. The aim of this study is to examine the effectiveness of smartphone education in colonoscopy.\\n\\n\\nMETHODS\\nWe conducted a prospective, double-blinded, randomized, controlled study to examine the effectiveness of smartphone education on embarrassment, bowel preparation, and satisfaction in colonoscopy. The patients' embarrassment was measured by the colonoscopy embarrassment scale. The quality of the bowel preparation was evaluated by gastroenterologists according to the Aronchik Scale. The satisfaction of colonoscopy care was assessed by a satisfaction scale developed by the authors.\\n\\n\\nRESULTS\\nA total of 150 patients were analyzed in the smartphone education and control groups (n\\u200a=\\u200a75 in each group). The smartphone education group reported fewer embarrassment (B\\u200a=\\u200a-2.78, P\\u200a=\\u200a.02) than those of the control group, the patients who were older (B\\u200a=\\u200a.15, P\\u200a=\\u200a.001) and who were male (B\\u200a=\\u200a2.91, P\\u200a=\\u200a.003) showed higher embarrassment. Additionally, smartphone education group were likely to have better colon preparation (odds ratio\\u200a=\\u200a2.46, 95% confidence interval: 1.20-5.02) than that of the control group. Smartphone education also improved the satisfaction with care (\\u200a=\\u200a4.60, P\\u200a<\\u200a.001), and above normal body mass index decreased the satisfaction with care (\\u200a=\\u200a-0.19, P\\u200a<\\u200a.05).\\n\\n\\nCONCLUSION\\nSmartphone education improves embarrassment, bowel preparation, and satisfaction with care in patients receiving colonoscopy.\",\n",
       "  'journal': 'Medicine',\n",
       "  'authors': 'MC Wen;K Kau;SS Huang;WH Huang;LY Tsai;TY Tsai;SL Tsay',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33181675',\n",
       "  'mesh_terms': 'D003113:Colonoscopy; D015179:Colorectal Neoplasms; D003194:Computer-Assisted Instruction; D004311:Double-Blind Method; D000078385:Embarrassment; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010349:Patient Compliance; D010353:Patient Education as Topic; D010549:Personal Satisfaction; D011300:Preoperative Care; D000068997:Smartphone',\n",
       "  'publication_types': 'D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/MD.0000000000023102',\n",
       "  'references': '21586673;30018478;12135020;17661246;21646636;31567921;25763558;30385831;25374492;30833965;29998024;28988890;31313807;19897823;12240927;29095417;30844973;15520425;31667695;18350339;27317249;28742732;28939500;17640455;22548424;26795085;23879593;30722114;21640543;29696175',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Diagnostic and therapeutic center of endoscopy and ultrasonography, China Medical University Hospital, Taichung.;Academic Writing Education Center, National Taiwan University, Taipei.;College of Nursing and Health Sciences, Da-Yeh University, Changhua.;Department of gastroenterology, China Medical University Hospital, Taichung, Taiwan.;College of Nursing and Health Sciences, Da-Yeh University, Changhua.;Department of gastroenterology, China Medical University Hospital, Taichung, Taiwan.;College of Nursing and Health Sciences, Da-Yeh University, Changhua.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Medicine (Baltimore)',\n",
       "  'nlm_unique_id': '2985248R',\n",
       "  'issn_linking': '0025-7974',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Therapies for Psoriasis: Clinical and Economic Comparisons.',\n",
       "  'abstract': 'Clinical and economic comparisons of therapies for plaque psoriasis are regularly updated following each new devel- opment in the field. With the recent availability of a novel accessory (Multi Micro DoseTM [MMD&reg;] tip) for the 308nm excimer laser (XTRAC&reg;, Strata Skin Sciences, Horsham, PA), which can determine and deliver an optimal therapeutic dose (OTDTM) of ultraviolet-B light in an improved protocol, the need for comparative health-economic assessment recurs. To this end, a comprehensive evaluation of treatment-related costs was undertaken from the payer perspective. Results show that outcomes are influenced by many factors; most importantly, the severity and extent of disease, treatment selection, and patient preference, as well as compliance, adherence, and persistence with care. Among study comparators, the 308nm excimer laser &ndash; XTRAC &ndash; with its latest MMD enhancement, is safe and delivers incremental clinical benefits with the potential for significant cost savings. These benefits are particularly relevant today in the context of SARS-CoV-2 virus and the COVid-19 pandemic. J Drugs Dermatol. 2020;19(11):1101-1108. doi:10.36849/JDD.2020.5510.',\n",
       "  'journal': 'Journal of drugs in dermatology : JDD',\n",
       "  'authors': 'A Marchetti;T Bhutani;B Lockshin;DM Siegel;F Behringer',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33196750',\n",
       "  'mesh_terms': 'D000086382:COVID-19; D018352:Coronavirus Infections; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006801:Humans; D054018:Lasers, Excimer; D058873:Pandemics; D010349:Patient Compliance; D057240:Patient Preference; D011024:Pneumonia, Viral; D011565:Psoriasis; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.36849/JDD.2020.5510',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Drugs Dermatol',\n",
       "  'nlm_unique_id': '101160020',\n",
       "  'issn_linking': '1545-9616',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Adherence to the Gluten-Free Diet during the Lockdown for COVID-19 Pandemic: A Web-Based Survey of Italian Subjects with Celiac Disease.',\n",
       "  'abstract': 'We aimed to assess the perceived impact of the lockdown, imposed to control the spreading of COVID-19, on the adherence of Italian celiac disease (CD) subjects to the gluten-free diet by a web-based survey. A total of 1983 responses were analyzed, 1614 (81.4%) by CD adults and 369 (18.6%) by parents/caregivers of CD children/adolescents. The compliance with the GFD was unchanged for 69% of the adults and 70% of the children, and improved for 29% of both. The factors increasing the probability to report stricter compliance were the presence of CD symptoms in the last year before the lockdown (odds ratio (OR) 1.98, 95% confidence interval (CI) 1.46-2.26), a partial usual adherence to gluten-free diet (GFD) (OR 1.91, 95% CI 1.2-3.06), and having tried recipes with naturally gluten-free ingredients more than usual (OR 1.58, 95% CI 1.28-1.96) for adults; the presence of CD symptoms in the last year (OR 2.05, 95% CI 1.21-3.47), still positive CD antibodies (OR 1.89, 95% CI 1.14-3.13), and other family members with CD (OR 2.24, 95% CI 1.3-3.85) for children/adolescents. Therefore, the lockdown led to a reported improved adherence to the GFD in one-third of the respondents, in particular in those with previous worse disease control, offering the opportunity to avoid sources of contamination/transgression and increase the use of naturally gluten-free products.',\n",
       "  'journal': 'Nutrients',\n",
       "  'authors': 'A Monzani;E Lionetti;E Felici;L Fransos;D Azzolina;I Rabbone;C Catassi',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33198212',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000073640:Betacoronavirus; D000086382:COVID-19; D002446:Celiac Disease; D002648:Child; D018352:Coronavirus Infections; D055050:Diet, Gluten-Free; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D058873:Pandemics; D010349:Patient Compliance; D011024:Pneumonia, Viral; D011790:Quarantine; D000086402:SARS-CoV-2; D011795:Surveys and Questionnaires; D055815:Young Adult',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'COVID-19; celiac disease; coronavirus; diet compliance; gluten-free diet; lockdown; telemedicine; web survey',\n",
       "  'doi': '10.3390/nu12113467',\n",
       "  'references': '32443021;30920417;32784530;33043562;33068666;33087204;27214084;32425731;32352652;33050404;30287732;33038479;15471760;33065991',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Division of Pediatrics, Department of Health Sciences, Universit del Piemonte Orientale, 28100 Novara, Italy.;Department of Pediatrics, Marche Polytechnic University, 60020 Ancona, Italy.;Pediatric and Pediatric Emergency Unit, Children Hospital, 15121 Alessandria, Italy.;Piedmont Section, Italian Celiac Association, 10136 Turin, Italy.;Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, Universit del Piemonte Orientale, 28100 Novara, Italy.;Division of Pediatrics, Department of Health Sciences, Universit del Piemonte Orientale, 28100 Novara, Italy.;Department of Pediatrics, Marche Polytechnic University, 60020 Ancona, Italy.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nutrients',\n",
       "  'nlm_unique_id': '101521595',\n",
       "  'issn_linking': '2072-6643',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Maternal perception of masking in children as a preventive strategy for COVID-19 in Nigeria: A multicentre study.',\n",
       "  'abstract': \"BACKGROUND\\nThe use of face masks by children for the prevention of COVID 19 is still controversial, especially with regards to who should wear the face mask and at what age.\\n\\n\\nOBJECTIVES\\nThe study aimed to ascertain the perception of mothers on masking in children as a preventive strategy for COVID-19.\\n\\n\\nMETHODOLOGY\\nThis was a cross-sectional study carried out in two health institutions among 387 mothers who presented with their children for the first time in the hospital during the COVID 19 pandemic. A pretested, semi-structured, interviewer-administered questionnaire which was designed by the researchers was used for data collection.\\n\\n\\nRESULTS\\nMinority (44.7%) of the mothers perceived masking in children as an appropriate measure for the prevention of COVID-19. The frequent reasons given by majority (55.3%) of the mothers for the inappropriateness of face mask in children included perceived difficulty in breathing (38.5%) and the child's readiness to pull it off (29.3%). A significantly higher proportion of the children whose mothers were 35 years and above, 64.2% would wear face masks when compared with 31.7% of those whose mothers were < 30 years of age (2 = 28.632, p<0.001). Similarly, a significantly higher proportion (51.0%) of the children who were more than one year of age would wear a face mask when compared with 20.5% of those aged eight days to one year (2 = 19.441, p<0.001). The children whose mothers were <30 years were about four times less likely to wear a face mask when compared with those whose mothers were aged 35 years and above. (AOR = 0.273; 95%CI: 0.155-0.478). The children whose fathers have attained tertiary education were about twice less likely to wear face masks when compared with those whose fathers have attained secondary education and less. (AOR = 0.554; 95%CI: 0.334-0.919). Mothers' perception of COVID-19 had no significant influence on children's use of face mask (2 = 2.337, p = 0.127).\\n\\n\\nCONCLUSION\\nMaternal perception of masking in children as an appropriate strategy for preventing COVID-19 is adjudged low in this study. Right perception is significantly enhanced by maternal educational status, employment and marital status.\",\n",
       "  'journal': 'PloS one',\n",
       "  'authors': 'AE Aronu;JM Chinawa;OC Nduagubam;EN Ossai;AT Chinawa;WC Igwe',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33211761',\n",
       "  'mesh_terms': 'D000328:Adult; D000073640:Betacoronavirus; D000086382:COVID-19; D002648:Child; D002675:Child, Preschool; D018352:Coronavirus Infections; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008397:Masks; D009035:Mothers; D009549:Nigeria; D058873:Pandemics; D010349:Patient Compliance; D011024:Pneumonia, Viral; D000086402:SARS-CoV-2; D011795:Surveys and Questionnaires; D055815:Young Adult',\n",
       "  'publication_types': 'D016428:Journal Article; D016448:Multicenter Study',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1371/journal.pone.0242650',\n",
       "  'references': '32273278;20569849;32187458;32145716;33119738;19815575;32125269;22312204;18042961;32273267;15539054;32171076;18612429;32220650;32205334',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Department of Paediatrics, College of Medicine, University of Nigeria Enugu Campus, Nsukka, Enugu, Nigeria.;Department of Paediatrics, College of Medicine, University of Nigeria Enugu Campus, Nsukka, Enugu, Nigeria.;Department of Paediatrics, Enugu State University Teaching Hospital, Nsukka, Enugu, Nigeria.;Department of Community Medicine, College of Health Sciences, Ebonyi State University Abakaliki, Abakaliki, Nigeria.;Consultant Community Physician and Lecturer Enugu State University Teaching Hospital, Nsukka, Enugu, Nigeria.;Department of Paediatrics, Nnamdi Azikiwe University Nnewi, Nnewi, Anambra, Nigeria.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'PLoS One',\n",
       "  'nlm_unique_id': '101285081',\n",
       "  'issn_linking': '1932-6203',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effectiveness of Innovation Media for Improving Physical Distancing Compliance during the COVID-19 Pandemic: A Quasi-Experiment in Thailand.',\n",
       "  'abstract': 'To flatten the curve of COVID-19 infections, with no effective pharmacological interventions or vaccine available in the imminent future, public health responses must continue to rely on non-pharmacological interventions. We developed three innovation media to promote physical distancing compliance (i.e., a fearful picture, a red one-way arrow sign, and a norm-speech sticker). This study aimed to compare physical distancing compliance between our interventions and conventional interventions. Our study was a quasi-experiment, and we observed a representative sample of university canteen customers via closed-circuit television (CCTV). Each intervention was monitored over non-prime-time hours, per day, on 6-9 August 2020. Among the 400 participants (100 participants in each group), their age group, gender, and physical distancing practices were observed in a university canteen. The number of failures of physical distancing ranged between 93.8% and 17.6%, and on average between 84.2% and 34.2%, dependent on the intervention and the marking point. There were no statistically significant differences in promoting physical distancing compliance between our interventions compared with conventional interventions. However, the participants tended to practice physical distancing at the back of the queue more than at the front, regardless of the interventions.',\n",
       "  'journal': 'International journal of environmental research and public health',\n",
       "  'authors': 'H Chutiphimon;A Thipsunate;A Cherdchim;B Boonyaphak;P Vithayasirikul;P Choothong;S Vichathai;P Ngamchaliew;P Vichitkunakorn',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33213080',\n",
       "  'mesh_terms': 'D000073640:Betacoronavirus; D000086382:COVID-19; D003140:Communicable Disease Control; D018352:Coronavirus Infections; D006801:Humans; D058873:Pandemics; D010349:Patient Compliance; D011024:Pneumonia, Viral; D000086402:SARS-CoV-2; D012934:Social Isolation; D013785:Thailand',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'COVID-19; innovation media; physical distancing',\n",
       "  'doi': '10.3390/ijerph17228535',\n",
       "  'references': '32220655;32434092;19797755;32029004;22511822;32497510;32269018;26784210;32305533;27475752',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Department of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.;Department of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Int J Environ Res Public Health',\n",
       "  'nlm_unique_id': '101238455',\n",
       "  'issn_linking': '1660-4601',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial.',\n",
       "  'abstract': 'OBJECTIVES\\n1. To compare the effectiveness of four different surveillance strategies in detecting COVID-19 within the homeless shelter population. 2. To assess the participant adherence over time for each surveillance method.\\n\\n\\nTRIAL DESIGN\\nThis is a prospective cluster-randomized study to compare the effectiveness of four different surveillance regimens across eight homeless shelters in the city of Hamilton.\\n\\n\\nPARTICIPANTS\\nParticipants will include both residents of, and the staff working within, the homeless shelters. All participants aged 18 or older who consent to the study and are able to collect a swab sample (where relevant) are eligible for the study. The study will take place across eight homeless shelters (four men-only and four women-only) in the City of Hamilton in Ontario, Canada.\\n\\n\\nINTERVENTION AND COMPARATOR GROUPS\\nThe comparator group will receive active daily surveillance of symptoms and testing will only be completed in symptomatic participants (i.e. those who fail screening or who seek care for potential COVID-19 related symptoms). The three intervention arms will all receive active daily surveillance of symptoms and testing of symptomatic participants (as in the comparator group) in addition to one of the following: 1. Once weekly self-collected oral swabs (OS) regardless of symptoms using written and visual instructions. 2. Once weekly self-collected oral-nares swab (O-NS) regardless of symptoms using written and visual instructions. 3. Once weekly nurse collected nasopharyngeal swab (NPS) regardless of symptoms. Participants will follow verbal and written instructions for the collection of OS and O-NS specimens. For OS collection, participants are instructed to first moisten the swab on their tongue, insert the swab between the cheek and the lower gums and rotate the swab three times. This is repeated on the other side. For O-NS collection, after oral collection, the swab is inserted comfortably (about 2-3 cm) into one nostril, parallel to the floor and turned three times, then repeated in the other nostril. NPS specimens were collected by the nurse following standard of care procedure. All swabs were placed into a viral inactivation medium and transported to the laboratory for COVID-19 testing. Briefly, total nucleic acid was extracted from specimens and then amplified by RT-PCR for the UTR and Envelope genes of SARS-CoV-2 and the human RNase P gene, which is used as a sample adequacy marker.\\n\\n\\nMAIN OUTCOMES\\n1.\\n\\n\\nPRIMARY OUTCOME\\nCOVID-19 detection rate, i.e. the number of new positive cases over the study period of 8 weeks in each arm of the study. 2.\\n\\n\\nSECONDARY OUTCOMES\\nQualitative assessment of study enrollment over 8 weeks. Percentage of participants who performed 50% or more of the weekly swabs in the intervention arms in the 8 week study period.\\n\\n\\nRANDOMIZATION\\nWe will use a computer-generated random assignment list to randomize the shelters to one of four interventions. Shelters were stratified by gender, and the simple randomization scheme was applied within each stratum. The randomization scheme was created using WinPEPI.\\n\\n\\nBLINDING\\nThis is an open-label study in which neither participants nor assessors are blinded.\\n\\n\\nNUMBERS TO BE RANDOMIZED (SAMPLE SIZE)\\nSince we are including our total sample frame, a sample size estimation at the cluster level is not required. However, if we succeed to enroll 50 participants per shelter from 8 shelters (n=400), and the detection rate is 3 times higher in the intervention groups (0.15) than in the comparator groups (0.05), we will have 90% power to detect a statistically significant and clinically important difference at a type I error rate of alpha=0.05 (one tailed), assuming an intraclass correlation of ~0.008. These computations were done using WinPEPI, and informed by conservative estimates from other studies on respiratory illness in the homeless (see Full protocol).\\n\\n\\nTRIAL STATUS\\nThe protocol version number is 3.0. Recruitment began on April 17, 2020 and is ongoing. Due to low numbers of COVID cases in the community and shelter system during the initial study period, the trial was extended. The estimated date for the end of the extended recruitment period is Feb 1, 2021.\\n\\n\\nTRIAL REGISTRATION\\nThe trial was registered with ClinicalTrials.gov on June 18, 2020 with the identifier NCT04438070 .\\n\\n\\nFULL PROTOCOL\\nThe full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.',\n",
       "  'journal': 'Trials',\n",
       "  'authors': \"T O'Shea;L Mbuagbaw;V Mokashi;D Bulir;J Gilchrist;N Smieja;S Chong;S Marttala;V Vera;A Cvetkovic;M Smieja\",\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33225995',\n",
       "  'mesh_terms': 'D000328:Adult; D000073640:Betacoronavirus; D000086382:COVID-19; D018352:Coronavirus Infections; D042241:Early Diagnosis; D005260:Female; D006703:Homeless Persons; D006801:Humans; D008297:Male; D008403:Mass Screening; D009864:Ontario; D058873:Pandemics; D010349:Patient Compliance; D011024:Pneumonia, Viral; D015397:Program Evaluation; D011446:Prospective Studies; D000086402:SARS-CoV-2; D013048:Specimen Handling; D013997:Time Factors',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'COVID-19; Randomized trial; homeless; prevention; protocol; screening; shelter; swabs',\n",
       "  'doi': '10.1186/s13063-020-04890-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': \"Department of Medicine (Infectious Diseases), Hamilton Shelter Health Network, Juravinski Hospital & Cancer Centre, McMaster University, A3-66, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada. osheat@mcmaster.ca.;Department of Health Research, Faculty of Health Sciences, Methods, Evidence and Impact, McMaster University, Hamilton, Canada.;Department of Medicine (Infectious Diseases), McMaster University, Hamilton, Canada.;Department of Medicine, Pathology and Molecular Medicine, Research St. Joseph's - Hamilton, McMaster University, Hamilton, ON, Canada.;Research St. Joseph's - Hamilton, Hamilton, ON, Canada.;Research St. Joseph's - Hamilton, Hamilton, ON, Canada.;Research St. Joseph's - Hamilton, Hamilton, ON, Canada.;Research St. Joseph's - Hamilton, Hamilton, ON, Canada.;Research St. Joseph's - Hamilton, Hamilton, ON, Canada.;Department of Medicine (Infectious Diseases), McMaster University, Hamilton, Canada.;Department of Medicine, Pathology and Molecular Medicine, Research St. Joseph's - Hamilton, McMaster University, Hamilton, ON, Canada.\",\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Trials',\n",
       "  'nlm_unique_id': '101263253',\n",
       "  'issn_linking': '1745-6215',\n",
       "  'country': 'England'},\n",
       " {'title': '[Adherence to the treatment of pa-tients in the long-term supervision period after myocardial infarction (according to the REGATA register)].',\n",
       "  'abstract': 'Aim To study long-term compliance with treatment in patients included into the REGistry of pATients after myocArdial infarction (REGATA).Material and methods In 2012-2013, the study included 481 patients with a history of myocardial infarction (MI) who visited the district outpatient clinic. Median age was 72 [62;78] years; men, 51.4\\u200a% (n=247); median time from the last MI to the date of inclusion into the registry was 5 [2;9] years. Compliance with treatment was determined with the Morisky-Green questionnaire during telephone contacts with patients at 36 and 48 months (n=230) after the inclusion. Patients scored 4 were considered compliant; patients scored 3 were low-compliant; and patients scored 0-2 were non-compliant. Statistical significance of differences in compliance at 36 and 48 months was assessed with the McNemar test.Results There were no significant differences between the proportions of compliant, low-compliant and non-compliant patients for the analyzed period. However, at 48 months after the inclusion, the number of patients who had difficulties in answering the questionnaire questions significantly increased from 15.5\\u200a% to 21.6\\u200a% (p=0.04). Analysis of changes in compliance with the treatment for only compliant patients showed that at 36 months from the inclusion, 87 patients remained highly compliant (37.8\\u200a%) while at 48 months, only 32 (36.8\\u200a%) patients remained compliant with the treatment. Proportion of compliant patients did not significantly differ for men and women, patients younger and older than 60 years, patients with primary MI and reinfarction, prone and not prone to self-management, and for those who used or not the medicine assistance.Conclusion The data obtained as a part of the REGATA registry indicate insufficient long-term compliance with the treatment of after-MI patients with both primary MI and reinfarction, an increasing proportion of patients who are unable to assess their degree of compliance, and decreasing compliance among highly compliant patients during the period between 36 and 48 months of observation. On the whole, there were no significant changes in the compliance with the treatment for 12 months between the first and the second interviews. The proportion of patients compliant with the prescribed drug therapy was significantly lower in the presence of predisposition to self-management.',\n",
       "  'journal': 'Kardiologiia',\n",
       "  'authors': 'KG Pereverzeva;SS Yakushin;MM Loukianov;OM Drapkina',\n",
       "  'pubdate': '2020',\n",
       "  'pmid': '33228508',\n",
       "  'mesh_terms': 'D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction; D010349:Patient Compliance; D012042:Registries',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.18087/cardio.2020.10.n1264',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': 'Ryazan State Medical University named after Academician I.P. Pavlov, Ryazan, Russia.;Ryazan State Medical University named after Academician I.P. Pavlov, Ryazan, Russia.;National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia.;National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia.',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Kardiologiia',\n",
       "  'nlm_unique_id': '0376351',\n",
       "  'issn_linking': '0022-9040',\n",
       "  'country': 'Russia (Federation)'}]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "empty3[13451:13461]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10692"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(empty)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "15055"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(empty1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "19018"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(empty2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "13461"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(empty3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Polypsychopharmacy.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Bulletin of the Menninger Clinic',\n",
       "  'authors': 'S Sturges;M Brown',\n",
       "  'pubdate': '1975',\n",
       "  'pmid': '110',\n",
       "  'mesh_terms': 'D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D004359:Drug Therapy, Combination; D006801:Humans; D001523:Mental Disorders; D010349:Patient Compliance; D011567:Psychiatric Department, Hospital; D011600:Psychopharmacology',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000978:Antiparkinson Agents; D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '15790987;16284219;17287242;17714991;19052045;20435867',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Bull Menninger Clin',\n",
       "  'nlm_unique_id': '7507032',\n",
       "  'issn_linking': '0025-9284',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Impact of psychosocial factors on the conduct of combined drug and psychotherapy research.',\n",
       "  'abstract': \"The effect of attitudes of therapists, patients and researchers on the conduct and outcome of combined drug and psychotherapy research was examined in a brief crisis-oriented psychotherapy clinic. Seventy-seven consecutive patients were given one of two anti-anxiety drugs or a placebo in conjunction with the typical psychoanalytically-oriented treatment used in the clinic. The therapists' attitudes favouring psychotherapy over drug therapy (and psychotherapy research) were clearly conveyed to the patients. Indicative of this are the following: (a) 82 per cent of the patients dropped out of drug taking, although a similar percentage remained in treatment; (b) only a third of the patients perceived it as being important to their therapists that they should take medication; (c) 87 per cent of the patients were rated as improved; and 75 per cent of patients completing forms considered that most or all of their improvement was attributable to talking. The research team, made up of members of the same department who therefore had similar values as the therapists, diligently collected outcome data, but ignored its responsibility to enforce drug-relation portions of the protocol. Overall, patients remained in therapy, improved and participated in completing forms, so that only the research goals of combined therapy were thwarted, while traditional clinic service and training goals proceeded as usual.\",\n",
       "  'journal': 'The British journal of psychiatry : the journal of mental science',\n",
       "  'authors': 'WN Stone;BL Green;GC Gleser;RM Whitman;BB Foster',\n",
       "  'pubdate': '1975',\n",
       "  'pmid': '1135',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D003258:Consumer Behavior; D003419:Crisis Intervention; D005260:Female; D006801:Humans; D007396:Internship and Residency; D007400:Interprofessional Relations; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011575:Psychoanalytic Therapy; D012107:Research Design; D012659:Semantic Differential',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1192/bjp.127.5.432',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Psychiatry',\n",
       "  'nlm_unique_id': '0342367',\n",
       "  'issn_linking': '0007-1250',\n",
       "  'country': 'England'},\n",
       " {'title': 'The expectation of outcome from maintenance therapy in chronic schizophrenic patients.',\n",
       "  'abstract': 'The results from a prospective follow-up study of a group of schizophrenic patients suggest that a significant proportion (41 per cent) are likely to relapse during a two-year period despite the prescription of long-acting injectable neuroleptic drugs. Some will relapse because of a failure of the regime, but others (32-37 per cent) because the pharmacological protection of these drugs would appear to be less effective in certain patients. Even with the major advantages of the long-acting injectable neuroleptics over oral medication, the schizophrenic patient population remains a group with a high incidence of psychiatric and social morbidity which continues to require the full resources of both the hospital and community services.',\n",
       "  'journal': 'The British journal of psychiatry : the journal of mental science',\n",
       "  'authors': 'DA Johnson',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '3251',\n",
       "  'mesh_terms': 'D010054:Brief Psychiatric Rating Scale; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D005500:Follow-Up Studies; D006801:Humans; D010349:Patient Compliance; D010352:Patient Dropouts; D010359:Patient Readmission; D011446:Prospective Studies; D012008:Recurrence; D012559:Schizophrenia; D012917:Social Adjustment; D013997:Time Factors; D014149:Tranquilizing Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003692:Delayed-Action Preparations; D014149:Tranquilizing Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1192/bjp.128.3.246',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Psychiatry',\n",
       "  'nlm_unique_id': '0342367',\n",
       "  'issn_linking': '0007-1250',\n",
       "  'country': 'England'},\n",
       " {'title': 'The current status of behavioral psychotherapy: theory and practice.',\n",
       "  'abstract': 'Behavioral psychotherapy has become one of the definitive treatments available for the relief of psychiatric suffering. Although hardly a panacea for all ills, the behavioral approach is the treatment of choice for certain selected problems. Behavioral methods make their contribution in the context of general psychiatric management and often must be used in conjunction with other treatment. The theoretical and practical aspects of behavioral psychotherapy have changed a great deal over the past few years and continue to evolve rapidly. Although useful molecular theories are emerging to guide the discipline, no global theory is likely to be satisfactory in the foreseeable future.',\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'IM Marks',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '3978',\n",
       "  'mesh_terms': 'D001007:Anxiety; D001521:Behavior Therapy; D003192:Compulsive Behavior; D003887:Desensitization, Psychologic; D006185:Habituation, Psychophysiologic; D006801:Humans; D009042:Motivation; D010349:Patient Compliance; D010698:Phobic Disorders; D011582:Psychological Theory; D009626:Terminology as Topic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.133.3.253',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Vasodilator administration in the presence of beta-adrenergic blockade.',\n",
       "  'abstract': 'To explore the possibility that the presence of propranolol-induced beta-adrenergic blockade might have an adverse effect upon homeostatic circulatory reflexes activated by the administration of a potent vasodilator agent, arterial blood pressure and pulse rate response to rapid intravenous diazoxide injection was monitored before and after pretreatment with propranolol in ten hypertensive patients. It appeared that beta-adrenergic blockade had no clinically significant effect on the magnitude of hypotension or the degree of heart rate acceleration induced by the administration of the potent vasodilator diazoxide. This reflex vasodilator-induced cardio-acceleration after propranolol adminstration could be the result of incomplete blockade of endogenously released neurotransmitter, inhibition of the parasympathetic nervous system, or a direct pharmacologic action of diazoxide. Diazoxide administration to hypertensive patients in the presence of beta-adrenergic blockade was not associated with any clinically significant hemodynamic consequences.',\n",
       "  'journal': 'Circulation',\n",
       "  'authors': 'WJ Mroczek;WR Lee;ME Davidov;FA Finnerty',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '5209',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists; D000328:Adult; D001794:Blood Pressure; D002319:Cardiovascular System; D003981:Diazoxide; D004347:Drug Interactions; D005260:Female; D006339:Heart Rate; D006439:Hemodynamics; D006805:Human Experimentation; D006801:Humans; D006973:Hypertension; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011292:Premedication; D011433:Propranolol; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011433:Propranolol; D003981:Diazoxide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.cir.53.6.985',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Circulation',\n",
       "  'nlm_unique_id': '0147763',\n",
       "  'issn_linking': '0009-7322',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Camazepam (SB/5833) in preparation for endoscopy inspection: open and double-blind study versus diazepam.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current therapeutic research, clinical and experimental',\n",
       "  'authors': 'G Galli',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '5249',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D002219:Carbamates; D002986:Clinical Trials as Topic; D003975:Diazepam; D004724:Endoscopy; D006801:Humans; D010349:Patient Compliance; D012018:Reflex',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D002219:Carbamates; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Ther Res Clin Exp',\n",
       "  'nlm_unique_id': '0372621',\n",
       "  'issn_linking': '0011-393X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Assessment of drugs in schizophrenia. Basic trial design.',\n",
       "  'abstract': 'Clinical trials with major tranquilizers must take into account the clinical features of patients with schizophrenia and pharmacokinetic and pharmacodynamic properties of the drug. The objectives of the trial must be carefully defined so that appropriate selection criteria for patients, rating instruments and dosage schedules can be selected. It is useful to monitor physiological and biochemical actions of major tranquilizers as well as the clinical effects.',\n",
       "  'journal': 'British journal of clinical pharmacology',\n",
       "  'authors': 'M Lader',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '9964',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004347:Drug Interactions; D006801:Humans; D010349:Patient Compliance; D012008:Recurrence; D012107:Research Design; D012559:Schizophrenia; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2125.1976.tb03728.x',\n",
       "  'references': '13730891;4577254;4584708;4692493;4715848;4936538;5014628;5017376;5081606;5335182',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Clin Pharmacol',\n",
       "  'nlm_unique_id': '7503323',\n",
       "  'issn_linking': '0306-5251',\n",
       "  'country': 'England'},\n",
       " {'title': 'Some effects of reduction in reinforcement magnitude in a monetary economy with hospitalized alcoholics.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Behaviour research and therapy',\n",
       "  'authors': 'LJ Boggs;V Rozynko;GA Flint',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '11769',\n",
       "  'mesh_terms': 'D000328:Adult; D000437:Alcoholism; D003887:Desensitization, Psychologic; D005260:Female; D006760:Hospitalization; D006801:Humans; D007206:Individuality; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012201:Reward',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0005-7967(76)90092-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Behav Res Ther',\n",
       "  'nlm_unique_id': '0372477',\n",
       "  'issn_linking': '0005-7967',\n",
       "  'country': 'England'},\n",
       " {'title': 'Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension.',\n",
       "  'abstract': \"Fifty-five patients with mild to moderate, renal or essential hypertension were admitted to a double blind cross-over trial of 18 weeks, involving treatment periods with placebo, the thiazide bendrofluazide (15 mg daily) and the beta blocker atenolol (600 mg daily). Compared to the placebo period (190/117 mm Hg) the hypotensive effect of atenolol (-24/16 mm Hg) was more pronounced than the hypotensive effect of bendrofluazide (-17/6 mm Hg). Arguments in favor of initiating antihypertensive drug therapy with beta blocker were its more powerful hypotensive effect, the quicker onset of its action, less metabolic disturbance, decreased frequency of complaints and patient's preference. On thiazides body weight and the frequency of swollen ankles decreased. Plasma renin concentration was not found to have a strong predicting power for the hypotensive effect of atenolol or bendrofluazide but low renin patients showed a more pronounced blood pressure decrease on bendrofluazide and high renin patients, especially essential hypertensives, on atenolol. While these points can be a guide to therapy today, the preference of one drug over the other must eventually be based on their relative efficacy in decreasing morbidity and mortality from the hypertensive disease.\",\n",
       "  'journal': 'Acta cardiologica',\n",
       "  'authors': 'R Fagard;A Amery;JF De Plaen;P Lijnen;A Missotten',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '14468',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D001262:Atenolol; D001539:Bendroflumethiazide; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension; D006977:Hypertension, Renal; D008297:Male; D010349:Patient Compliance; D010919:Placebos; D011412:Propanolamines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011412:Propanolamines; D001262:Atenolol; D001539:Bendroflumethiazide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Cardiol',\n",
       "  'nlm_unique_id': '0370570',\n",
       "  'issn_linking': '0001-5385',\n",
       "  'country': 'England'},\n",
       " {'title': 'The general management of hypertension.',\n",
       "  'abstract': '',\n",
       "  'journal': 'Australian and New Zealand journal of medicine',\n",
       "  'authors': '',\n",
       "  'pubdate': '1976',\n",
       "  'pmid': '14615',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000368:Aged; D000818:Animals; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003000:Clonidine; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension; D006974:Hypertension, Malignant; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D051381:Rats; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1445-5994.1976.tb03345.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aust N Z J Med',\n",
       "  'nlm_unique_id': '1264322',\n",
       "  'issn_linking': '0004-8291',\n",
       "  'country': 'Australia'}]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "full_PC_MeSH=[]\n",
    "for i in empty:\n",
    "    full_PC_MeSH.append(i)\n",
    "full_PC_MeSH[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10692"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(full_PC_MeSH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in empty1:\n",
    "    full_PC_MeSH.append(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "25747"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(full_PC_MeSH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in empty2:\n",
    "    full_PC_MeSH.append(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "44765"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(full_PC_MeSH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in empty3:\n",
    "    full_PC_MeSH.append(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "58226"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(full_PC_MeSH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pickle \n",
    "with open(\"Full_PC_MeSH\", \"wb\") as hp:   #Pickling\n",
    "    pickle.dump(full_PC_MeSH, hp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
